Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 678 articles:
HTML format



Single Articles


    July 2024
  1. FERRER-ORTA C, Vazquez-Monteagudo S, Ferrero DS, Martinez-Gonzalez B, et al
    Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2024;121:e2317977121.
    PubMed     Abstract available


  2. PERLMAN S
    A balance between innovation and biosafety.
    Proc Natl Acad Sci U S A. 2024;121:e2410451121.
    PubMed    


  3. HU Z, Lopez-Munoz AD, Kosik I, Li T, et al
    Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
    Proc Natl Acad Sci U S A. 2024;121:e2310421121.
    PubMed     Abstract available


  4. WU Q, Rafatian N, Wagner KT, Blamer J, et al
    SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening.
    Proc Natl Acad Sci U S A. 2024;121:e2403581121.
    PubMed     Abstract available


  5. PURCELL H, Kohler IV, Ciancio A, Mwera J, et al
    Mortality risk information and health-seeking behavior during an epidemic.
    Proc Natl Acad Sci U S A. 2024;121:e2315677121.
    PubMed     Abstract available


  6. DE LA PRADA AG, Small ML
    How people are exposed to neighborhoods racially different from their own.
    Proc Natl Acad Sci U S A. 2024;121:e2401661121.
    PubMed     Abstract available


    June 2024
  7. KIM H, Park HH, Kim HN, Seo D, et al
    The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases.
    Proc Natl Acad Sci U S A. 2024;121:e2319322121.
    PubMed     Abstract available


  8. TORTORICE D, Rappuoli R, Bloom DE
    The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2321978121.
    PubMed     Abstract available


  9. GUILLEN JV, Glaunsinger BA
    SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection.
    Proc Natl Acad Sci U S A. 2024;121:e2408794121.
    PubMed    


  10. DONKER T, Papathanassopoulos A, Ghosh H, Kociurzynski R, et al
    Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.
    Proc Natl Acad Sci U S A. 2024;121:e2314262121.
    PubMed     Abstract available


  11. AFROZ S, Saul S, Dai J, Surman S, et al
    Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Proc Natl Acad Sci U S A. 2024;121:e2316376121.
    PubMed     Abstract available


  12. MCGOUGH L, Cobey S
    A speed limit on serial strain replacement from original antigenic sin.
    Proc Natl Acad Sci U S A. 2024;121:e2400202121.
    PubMed     Abstract available


  13. GUO YT, Jiang JB, Qiao GR, Luo RH, et al
    Pleiotropy of positive selection in ancient ACE2 suggests an alternative hypothesis for bat-specific adaptations to host coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2321619121.
    PubMed     Abstract available


  14. WANG D, Huot M, Mohanty V, Shakhnovich EI, et al
    Biophysical principles predict fitness of SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2024;121:e2314518121.
    PubMed     Abstract available


  15. QU B, Miskey C, Gomer A, Kleinert RDV, et al
    TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
    Proc Natl Acad Sci U S A. 2024;121:e2407437121.
    PubMed     Abstract available


    May 2024
  16. KITAMURA S, Lin TH, Lee CD, Takamura A, et al
    Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
    Proc Natl Acad Sci U S A. 2024;121:e2310677121.
    PubMed     Abstract available


  17. LICHAND G, Doria CA
    The lasting impacts of remote learning in the absence of remedial policies: Evidence from Brazil.
    Proc Natl Acad Sci U S A. 2024;121:e2316300121.
    PubMed     Abstract available


  18. LAL A, Thompson DM
    Did private election administration funding advantage Democrats in 2020?
    Proc Natl Acad Sci U S A. 2024;121:e2317563121.
    PubMed     Abstract available


  19. ENDEVELT K, Halperin E, Porat R
    Zoom out: An intervention on the virtual learning environment improves minority students' grades in two field experiments in Israel.
    Proc Natl Acad Sci U S A. 2024;121:e2313496121.
    PubMed     Abstract available


  20. MEI M, Cupic A, Miorin L, Ye C, et al
    Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.
    Proc Natl Acad Sci U S A. 2024;121:e2314166121.
    PubMed     Abstract available


  21. OTTER CJ, Renner DM, Fausto A, Tan LH, et al
    Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2402540121.
    PubMed     Abstract available


  22. XIE Y, Yang F, Huang J, He Y, et al
    Declining Chinese attitudes toward the United States amid COVID-19.
    Proc Natl Acad Sci U S A. 2024;121:e2322920121.
    PubMed     Abstract available


  23. MORALES M, Yang MY, Goddard WA 3rd, Gray HB, et al
    Copper(II) coordination to the intrinsically disordered region of SARS-CoV-2 Nsp1.
    Proc Natl Acad Sci U S A. 2024;121:e2402653121.
    PubMed     Abstract available


    April 2024
  24. MAO T, Kim J, Pena-Hernandez MA, Valle G, et al
    Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract.
    Proc Natl Acad Sci U S A. 2024;121:e2319566121.
    PubMed     Abstract available


  25. KUNG CSJ, Steptoe A
    Changes in well-being among socially isolated older people during the COVID-19 pandemic: An outcome-wide analysis.
    Proc Natl Acad Sci U S A. 2024;121:e2308697121.
    PubMed     Abstract available


  26. FREEDMAN AS, Sheen JK, Tsai S, Yao J, et al
    Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.
    Proc Natl Acad Sci U S A. 2024;121:e2314357121.
    PubMed     Abstract available


  27. JOHANNESEN N, Tang-Andersen Martinello A, Meyer BB, Vestergaard ET, et al
    Substantial transmission of SARS-CoV-2 through casual contact in retail stores: Evidence from matched administrative microdata on card payments and testing.
    Proc Natl Acad Sci U S A. 2024;121:e2317589121.
    PubMed     Abstract available


  28. OTTER CJ, Bracci N, Parenti NA, Ye C, et al
    SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
    Proc Natl Acad Sci U S A. 2024;121:e2320194121.
    PubMed     Abstract available


  29. TAN TJC, Verma AK, Odle A, Lei R, et al
    Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike.
    Proc Natl Acad Sci U S A. 2024;121:e2317222121.
    PubMed     Abstract available


  30. BABOUN J, Beaudry IS, Castro LM, Gutierrez F, et al
    Identifying outbreaks in sewer networks: An adaptive sampling scheme under network's uncertainty.
    Proc Natl Acad Sci U S A. 2024;121:e2316616121.
    PubMed     Abstract available


    March 2024
  31. FLECKENSTEIN F, Stephan S, Hasse H
    Elucidating the behavior of the SARS-CoV-2 virus surface at vapor-liquid interfaces using molecular dynamics simulation.
    Proc Natl Acad Sci U S A. 2024;121:e2317194121.
    PubMed     Abstract available


  32. GAO R, Xu X, Kumar P, Liu Y, et al
    Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2024;121:e2310469121.
    PubMed     Abstract available


  33. CAHUANTZI R, Lythgoe KA, Hall I, Pellis L, et al
    Unsupervised identification of significant lineages of SARS-CoV-2 through scalable machine learning methods.
    Proc Natl Acad Sci U S A. 2024;121:e2317284121.
    PubMed     Abstract available


  34. DELGADO S, Somovilla P, Ferrer-Orta C, Martinez-Gonzalez B, et al
    Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.
    Proc Natl Acad Sci U S A. 2024;121:e2317851121.
    PubMed     Abstract available


  35. LIAO Z, Wang C, Tang X, Yang M, et al
    Human transferrin receptor can mediate SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2024;121:e2317026121.
    PubMed     Abstract available


  36. CHANG S, Shin KS, Park B, Park S, et al
    Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
    Proc Natl Acad Sci U S A. 2024;121:e2313681121.
    PubMed     Abstract available


  37. KRETSCH RC, Xu L, Zheludev IN, Zhou X, et al
    Tertiary folds of the SL5 RNA from the 5' proximal region of SARS-CoV-2 and related coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2320493121.
    PubMed     Abstract available


    February 2024
  38. RAINS SA, Richards AS
    US state vaccine mandates did not influence COVID-19 vaccination rates but reduced uptake of COVID-19 boosters and flu vaccines compared to bans on vaccine restrictions.
    Proc Natl Acad Sci U S A. 2024;121:e2313610121.
    PubMed     Abstract available


  39. ZHAO G, Xue L, Geisler HC, Xu J, et al
    Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery.
    Proc Natl Acad Sci U S A. 2024;121:e2314747121.
    PubMed     Abstract available


  40. ZHANG Y, Bharathi V, Dokoshi T, de Anda J, et al
    Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes.
    Proc Natl Acad Sci U S A. 2024;121:e2300644120.
    PubMed     Abstract available


  41. PAGLINO E, Lundberg DJ, Wrigley-Field E, Zhou Z, et al
    Excess natural-cause mortality in US counties and its association with reported COVID-19 deaths.
    Proc Natl Acad Sci U S A. 2024;121:e2313661121.
    PubMed     Abstract available


    January 2024
  42. MEYNIEL-SCHICKLIN L, Amaudrut J, Mallinjoud P, Guillier F, et al
    Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery.
    Proc Natl Acad Sci U S A. 2024;121:e2308776121.
    PubMed     Abstract available


  43. PACIELLO I, Maccari G, Pantano E, Andreano E, et al
    High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2024;121:e2314730121.
    PubMed     Abstract available


  44. DEE TS
    Higher chronic absenteeism threatens academic recovery from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2312249121.
    PubMed     Abstract available


  45. GOTTLIEB A, Pham HPT, Saltarrelli JG, Lindsey JW, et al
    Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells.
    Proc Natl Acad Sci U S A. 2024;121:e2315857121.
    PubMed     Abstract available


  46. YU J, Zhao W, Chen X, Lu H, et al
    A plant virus manipulates the long-winged morph of insect vectors.
    Proc Natl Acad Sci U S A. 2024;121:e2315341121.
    PubMed     Abstract available


  47. BAUM MY, Jacob BA
    Racial differences in parent response to COVID schooling policies.
    Proc Natl Acad Sci U S A. 2024;121:e2307308120.
    PubMed     Abstract available


  48. DIDIER G, Glatt-Holtz NE, Holbrook AJ, Magee AF, et al
    On the surprising effectiveness of a simple matrix exponential derivative approximation, with application to global SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2024;121:e2318989121.
    PubMed     Abstract available


  49. VAUGHAN TG, Scire J, Nadeau SA, Stadler T, et al
    Estimates of early outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data.
    Proc Natl Acad Sci U S A. 2024;121:e2308125121.
    PubMed     Abstract available


  50. FINNEY J, Moseman AP, Kong S, Watanabe A, et al
    Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin.
    Proc Natl Acad Sci U S A. 2024;121:e2316964120.
    PubMed     Abstract available


  51. CHEN Y, Gel YR, Marathe MV, Poor HV, et al
    A simplicial epidemic model for COVID-19 spread analysis.
    Proc Natl Acad Sci U S A. 2024;121:e2313171120.
    PubMed     Abstract available


    December 2023
  52. RAO X, Zhao R, Tong Z, Guo S, et al
    Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2314193120.
    PubMed     Abstract available


  53. YE Z, Bonam SR, McKay LGA, Plante JA, et al
    Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants.
    Proc Natl Acad Sci U S A. 2023;120:e2311752120.
    PubMed     Abstract available


  54. MIYAMOTO S, Nishiyama T, Ueno A, Park H, et al
    Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2023;120:e2314808120.
    PubMed     Abstract available


  55. STUMPFF JP 2ND, Kim SY, McFadden MI, Nishida A, et al
    Pleural macrophages translocate to the lung during infection to promote improved influenza outcomes.
    Proc Natl Acad Sci U S A. 2023;120:e2300474120.
    PubMed     Abstract available


  56. NAPOLI L, Sekara V, Garcia-Herranz M, Karsai M, et al
    Socioeconomic reorganization of communication and mobility networks in response to external shocks.
    Proc Natl Acad Sci U S A. 2023;120:e2305285120.
    PubMed     Abstract available


  57. ZHANG H, Wang Z, Nguyen HTT, Watson AJ, et al
    Integrin alpha(5)beta(1) contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction.
    Proc Natl Acad Sci U S A. 2023;120:e2311913120.
    PubMed     Abstract available


  58. IOANNIDIS JPA, Zonta F, Levitt M
    Variability in excess deaths across countries with different vulnerability during 2020-2023.
    Proc Natl Acad Sci U S A. 2023;120:e2309557120.
    PubMed     Abstract available


  59. TURNER CA, Khalil H, Murphy-Weinberg V, Hagenauer MH, et al
    The impact of COVID-19 on a college freshman sample reveals genetic and nongenetic forms of susceptibility and resilience to stress.
    Proc Natl Acad Sci U S A. 2023;120:e2305779120.
    PubMed     Abstract available


  60. TORCHE F, Nobles J
    Vaccination, immunity, and the changing impact of COVID-19 on infant health.
    Proc Natl Acad Sci U S A. 2023;120:e2311573120.
    PubMed     Abstract available


  61. CHENG CW, Wu CY, Wang SW, Chen JY, et al
    Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA).
    Proc Natl Acad Sci U S A. 2023;120:e2314392120.
    PubMed     Abstract available


    November 2023
  62. ESPINOZA B, Adiga A, Venkatramanan S, Warren AS, et al
    Coupled models of genomic surveillance and evolving pandemics with applications for timely public health interventions.
    Proc Natl Acad Sci U S A. 2023;120:e2305227120.
    PubMed     Abstract available


  63. CONDOR CAPCHA JM, Kamiar A, Robleto E, Saad AG, et al
    Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.
    Proc Natl Acad Sci U S A. 2023;120:e2308342120.
    PubMed     Abstract available


  64. CHEN Y, Lei X, Jiang Z, Humphries F, et al
    Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates.
    Proc Natl Acad Sci U S A. 2023;120:e2308355120.
    PubMed     Abstract available


  65. ALTMEJD A, Ostergren O, Bjorkegren E, Persson T, et al
    Inequality and COVID-19 in Sweden: Relative risks of nine bad life events, by four social gradients, in pandemic vs. prepandemic years.
    Proc Natl Acad Sci U S A. 2023;120:e2303640120.
    PubMed     Abstract available


  66. PETRONE ME, Parry R, Mifsud JCO, Van Brussel K, et al
    Evidence for an ancient aquatic origin of the RNA viral order Articulavirales.
    Proc Natl Acad Sci U S A. 2023;120:e2310529120.
    PubMed     Abstract available


  67. ZHOU J, Sukhova K, Peacock TP, McKay PF, et al
    Omicron breakthrough infections in vaccinated or previously infected hamsters.
    Proc Natl Acad Sci U S A. 2023;120:e2308655120.
    PubMed     Abstract available


    October 2023
  68. EDGAR JE, Trezise S, Anthony RM, Krammer F, et al
    Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcgammaR-dependent protection in vivo.
    Proc Natl Acad Sci U S A. 2023;120:e2314905120.
    PubMed     Abstract available


  69. CHARDES V, Mazzolini A, Mora T, Walczak AM, et al
    Evolutionary stability of antigenically escaping viruses.
    Proc Natl Acad Sci U S A. 2023;120:e2307712120.
    PubMed     Abstract available


  70. FISCHER H, Huff M, Anders G, Said N, et al
    Metacognition, public health compliance, and vaccination willingness.
    Proc Natl Acad Sci U S A. 2023;120:e2105425120.
    PubMed     Abstract available


  71. WISSLER A, DeWitte SN
    Frailty and survival in the 1918 influenza pandemic.
    Proc Natl Acad Sci U S A. 2023;120:e2304545120.
    PubMed     Abstract available


  72. ZHANG J, Tan S, Peng C, Xu X, et al
    Heterogeneous changes in mobility in response to the SARS-CoV-2 Omicron BA.2 outbreak in Shanghai.
    Proc Natl Acad Sci U S A. 2023;120:e2306710120.
    PubMed     Abstract available


  73. HART WS, Park H, Jeong YD, Kim KS, et al
    Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study.
    Proc Natl Acad Sci U S A. 2023;120:e2305451120.
    PubMed     Abstract available


  74. SCHLUTER M, Brelsford C, Ferraro PJ, Orach K, et al
    Unraveling complex causal processes that affect sustainability requires more integration between empirical and modeling approaches.
    Proc Natl Acad Sci U S A. 2023;120:e2215676120.
    PubMed     Abstract available


  75. ZHAO P, Liu Q, Ma T, Kang T, et al
    Policy instruments facilitate China's COVID-19 work resumption.
    Proc Natl Acad Sci U S A. 2023;120:e2305692120.
    PubMed     Abstract available


  76. XU J, Zhang Y, Qu P, Shamseldin MM, et al
    A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
    Proc Natl Acad Sci U S A. 2023;120:e2220403120.
    PubMed     Abstract available


    September 2023
  77. HUANG R, Warner Jenkins G, Kim Y, Stanfield RL, et al
    The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2303455120.
    PubMed     Abstract available


  78. TAO Y, Yang L, Jaffe S, Amini F, et al
    Climate mitigation potentials of teleworking are sensitive to changes in lifestyle and workplace rather than ICT usage.
    Proc Natl Acad Sci U S A. 2023;120:e2304099120.
    PubMed     Abstract available


  79. GUSEMAN AJ, Rennick LJ, Nambulli S, Roy CN, et al
    Targeting spike glycans to inhibit SARS-CoV2 viral entry.
    Proc Natl Acad Sci U S A. 2023;120:e2301518120.
    PubMed     Abstract available


  80. XU H, Zhong Y, Yang J, Fu L, et al
    Reply to Yan et al.: Quercetin possesses a fluorescence quenching effect but is a weak inhibitor against SARS-CoV-2 main protease.
    Proc Natl Acad Sci U S A. 2023;120:e2309870120.
    PubMed    


  81. YAN H, Zhang R, Liu X, Wang Y, et al
    Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease.
    Proc Natl Acad Sci U S A. 2023;120:e2309289120.
    PubMed    


    August 2023
  82. ZHANG Q
    Complex Interplay between Population Immunity and Viral Dynamics.
    Proc Natl Acad Sci U S A. 2023;120:e2312198120.
    PubMed    


  83. ALHAMMAD YM, Parthasarathy S, Ghimire R, Kerr CM, et al
    SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.
    Proc Natl Acad Sci U S A. 2023;120:e2302083120.
    PubMed     Abstract available


  84. CIROVIC A, Cirovic A
    Could iron deficiency potentiate the appearance of complications in Influenza A virus infection?
    Proc Natl Acad Sci U S A. 2023;120:e2311262120.
    PubMed    


  85. BOLTON MJ, Santos JJS, Arevalo CP, Griesman T, et al
    IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding.
    Proc Natl Acad Sci U S A. 2023;120:e2216521120.
    PubMed     Abstract available


  86. RAO Z, Brunner E, Giszas B, Iyer-Bierhoff A, et al
    Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution.
    Proc Natl Acad Sci U S A. 2023;120:e2302070120.
    PubMed     Abstract available


  87. BAILEY MJ, Currie J, Schwandt H
    The COVID-19 baby bump in the United States.
    Proc Natl Acad Sci U S A. 2023;120:e2222075120.
    PubMed     Abstract available


  88. STAQUICINI DI, Cardo-Vila M, Rotolo JA, Staquicini FI, et al
    Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.
    Proc Natl Acad Sci U S A. 2023;120:e2220269120.
    PubMed     Abstract available


  89. WANG PY, Ma J, Kim YC, Son AY, et al
    WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome.
    Proc Natl Acad Sci U S A. 2023;120:e2302738120.
    PubMed     Abstract available


  90. MANRUBIA S, Cuesta JA
    Physics of diffusion in viral genome evolution.
    Proc Natl Acad Sci U S A. 2023;120:e2310999120.
    PubMed    


  91. MAIO N, Raza MK, Li Y, Zhang DL, et al
    An iron-sulfur cluster in the zinc-binding domain of the SARS-CoV-2 helicase modulates its RNA-binding and -unwinding activities.
    Proc Natl Acad Sci U S A. 2023;120:e2303860120.
    PubMed     Abstract available


  92. ZELLER MA, Ma J, Wong FY, Tum S, et al
    The genomic landscape of swine influenza A viruses in Southeast Asia.
    Proc Natl Acad Sci U S A. 2023;120:e2301926120.
    PubMed     Abstract available


  93. YANG L, Wang Z, Wang L, Vrancken B, et al
    Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2305403120.
    PubMed     Abstract available


  94. TSANG TK, Wang C, Fang VJ, Perera RAPM, et al
    Reconstructing household transmission dynamics to estimate the infectiousness of asymptomatic influenza virus infections.
    Proc Natl Acad Sci U S A. 2023;120:e2304750120.
    PubMed     Abstract available


  95. SHEPHERD SJ, Han X, Mukalel AJ, El-Mayta R, et al
    Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines.
    Proc Natl Acad Sci U S A. 2023;120:e2303567120.
    PubMed     Abstract available


  96. BILINSKI AM, Salomon JA, Hatfield LA
    Adaptive metrics for an evolving pandemic: A dynamic approach to area-level COVID-19 risk designations.
    Proc Natl Acad Sci U S A. 2023;120:e2302528120.
    PubMed     Abstract available


  97. BADER SM, Cooney JP, Sheerin D, Taiaroa G, et al
    SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates.
    Proc Natl Acad Sci U S A. 2023;120:e2301689120.
    PubMed     Abstract available


  98. LIU M, Bakker AS, Narimatsu Y, van Kuppeveld FJM, et al
    H3N2 influenza A virus gradually adapts to human-type receptor binding and entry specificity after the start of the 1968 pandemic.
    Proc Natl Acad Sci U S A. 2023;120:e2304992120.
    PubMed     Abstract available


  99. KESHAVIAH A, Huff I, Hu XC, Guidry V, et al
    Separating signal from noise in wastewater data: An algorithm to identify community-level COVID-19 surges in real time.
    Proc Natl Acad Sci U S A. 2023;120:e2216021120.
    PubMed     Abstract available


  100. CHANG TY, Jacobson M, Shah M, Kopetsky M, et al
    Reminders, but not monetary incentives, increase COVID-19 booster uptake.
    Proc Natl Acad Sci U S A. 2023;120:e2302725120.
    PubMed     Abstract available


  101. LI P, Xue B, Schnicker NJ, Wong LR, et al
    Nsp3-N interactions are critical for SARS-CoV-2 fitness and virulence.
    Proc Natl Acad Sci U S A. 2023;120:e2305674120.
    PubMed     Abstract available


  102. CHAN JCK, Ahn D
    Unproctored online exams provide meaningful assessment of student learning.
    Proc Natl Acad Sci U S A. 2023;120:e2302020120.
    PubMed     Abstract available


    July 2023
  103. ALTANGEREL N, Neuman BW, Hemmer PR, Yakovlev VV, et al
    Label-free drug interaction screening via Raman microscopy.
    Proc Natl Acad Sci U S A. 2023;120:e2218826120.
    PubMed     Abstract available


  104. QIAO Y, Wotring JW, Zheng Y, Zhang CJ, et al
    Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
    Proc Natl Acad Sci U S A. 2023;120:e2221809120.
    PubMed     Abstract available


  105. GOIRIZ L, Ruiz R, Garibo-I-Orts O, Conejero JA, et al
    A variant-dependent molecular clock with anomalous diffusion models SARS-CoV-2 evolution in humans.
    Proc Natl Acad Sci U S A. 2023;120:e2303578120.
    PubMed     Abstract available


  106. ASANOV I, Asanov AM, Astebro T, Buenstorf G, et al
    System-, teacher-, and student-level interventions for improving participation in online learning at scale in high schools.
    Proc Natl Acad Sci U S A. 2023;120:e2216686120.
    PubMed     Abstract available


  107. ZHANG P, Falcone S, Tsybovsky Y, Singh M, et al
    Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles.
    Proc Natl Acad Sci U S A. 2023;120:e2305896120.
    PubMed     Abstract available


  108. PRASAD PV, Steele MK, Reed C, Meyers LA, et al
    Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics.
    Proc Natl Acad Sci U S A. 2023;120:e2300590120.
    PubMed     Abstract available


  109. LOPEZ-MUNOZ AD, Santos JJS, Yewdell JW
    Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy.
    Proc Natl Acad Sci U S A. 2023;120:e2304087120.
    PubMed     Abstract available


    June 2023
  110. JONES NM, Thompson RR, Holman EA, Silver RC, et al
    Idiosyncratic media exposures during a pandemic and their link to well-being, cognition, and behavior over time.
    Proc Natl Acad Sci U S A. 2023;120:e2304550120.
    PubMed     Abstract available


  111. THIJSSEN V, Hurdiss DL, Debski-Antoniak OJ, Spence MA, et al
    A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein.
    Proc Natl Acad Sci U S A. 2023;120:e2303292120.
    PubMed     Abstract available


  112. LIU K, Tang M, Xu W, Meng X, et al
    An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo.
    Proc Natl Acad Sci U S A. 2023;120:e2207210120.
    PubMed     Abstract available


  113. TRAULSEN A, Levin SA, Saad-Roy CM
    Individual costs and societal benefits of interventions during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2023;120:e2303546120.
    PubMed     Abstract available


  114. MISSON MINDREBO L, Liu H, Ozorowski G, Tran Q, et al
    Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
    Proc Natl Acad Sci U S A. 2023;120:e2216612120.
    PubMed     Abstract available


  115. SOOD M, Sridhar A, Eletreby R, Wu CW, et al
    Spreading processes with mutations over multilayer networks.
    Proc Natl Acad Sci U S A. 2023;120:e2302245120.
    PubMed     Abstract available


  116. GUENTHOER J, Lilly M, Starr TN, Dadonaite B, et al
    Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection.
    Proc Natl Acad Sci U S A. 2023;120:e2220948120.
    PubMed     Abstract available


  117. TADA T, Minnee J, Landau NR
    Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model.
    Proc Natl Acad Sci U S A. 2023;120:e2303509120.
    PubMed     Abstract available


    May 2023
  118. PETERSEN M, Nagele FL, Mayer C, Schell M, et al
    Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2023;120:e2217232120.
    PubMed     Abstract available


  119. PANDEY JP
    Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs.
    Proc Natl Acad Sci U S A. 2023;120:e2306078120.
    PubMed    


  120. PARK SW, Sun K, Abbott S, Sender R, et al
    Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2221887120.
    PubMed     Abstract available


  121. HOSOYA T, Oba S, Komiya Y, Kawata D, et al
    Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19.
    Proc Natl Acad Sci U S A. 2023;120:e2300155120.
    PubMed     Abstract available


  122. SCHUMM B, Bremer S, Knodlseder K, Schonfelder M, et al
    Lung aerosol particle emission increases with age at rest and during exercise.
    Proc Natl Acad Sci U S A. 2023;120:e2301145120.
    PubMed     Abstract available


  123. MAZEL-SANCHEZ B, Niu C, Williams N, Bachmann M, et al
    Influenza A virus exploits transferrin receptor recycling to enter host cells.
    Proc Natl Acad Sci U S A. 2023;120:e2214936120.
    PubMed     Abstract available


  124. BARRETO EA, Cruz AS, Veras FP, Martins R, et al
    COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis.
    Proc Natl Acad Sci U S A. 2023;120:e2217119120.
    PubMed     Abstract available


  125. TREVISIN C, Bertuzzo E, Pasetto D, Mari L, et al
    Spatially explicit effective reproduction numbers from incidence and mobility data.
    Proc Natl Acad Sci U S A. 2023;120:e2219816120.
    PubMed     Abstract available


  126. HARTON M, Kinzy TG, Bear A
    Monitoring and addressing the long-term impacts of the COVID-19 pandemic on women in academic science, engineering, and medicine.
    Proc Natl Acad Sci U S A. 2023;120:e2304603120.
    PubMed    


  127. EASTERLIN RA, O'Connor KJ
    Three years of COVID-19 and life satisfaction in Europe: A macro view.
    Proc Natl Acad Sci U S A. 2023;120:e2300717120.
    PubMed     Abstract available


  128. SHEA K, Borchering RK, Probert WJM, Howerton E, et al
    Multiple models for outbreak decision support in the face of uncertainty.
    Proc Natl Acad Sci U S A. 2023;120:e2207537120.
    PubMed     Abstract available


  129. SONG Y, Yao H, Wu N, Xu J, et al
    In situ architecture and membrane fusion of SARS-CoV-2 Delta variant.
    Proc Natl Acad Sci U S A. 2023;120:e2213332120.
    PubMed     Abstract available


  130. EINAV L, Finkelstein A
    The risk of losing health insurance in the United States is large, and remained so after the Affordable Care Act.
    Proc Natl Acad Sci U S A. 2023;120:e2222100120.
    PubMed     Abstract available


  131. XU H, Li S, Liu J, Cheng J, et al
    Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.
    Proc Natl Acad Sci U S A. 2023;120:e2301775120.
    PubMed     Abstract available


    April 2023
  132. LI C, Huang J, Yu Y, Wan Z, et al
    Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants.
    Proc Natl Acad Sci U S A. 2023;120:e2300376120.
    PubMed     Abstract available


  133. ZHANG J, Yang W, Roy S, Liu H, et al
    Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission.
    Proc Natl Acad Sci U S A. 2023;120:e2218623120.
    PubMed     Abstract available


  134. GUINAT C, Tang H, Yang Q, Valenzuela Agui C, et al
    Bayesian phylodynamics reveals the transmission dynamics of avian influenza A(H7N9) virus at the human-live bird market interface in China.
    Proc Natl Acad Sci U S A. 2023;120:e2215610120.
    PubMed     Abstract available


  135. LEE CY, Raghunathan V, Caceres CJ, Geiger G, et al
    Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies.
    Proc Natl Acad Sci U S A. 2023;120:e2208718120.
    PubMed     Abstract available


  136. MORIYAMA M, Lucas C, Monteiro VS, Iwasaki A, et al
    Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants.
    Proc Natl Acad Sci U S A. 2023;120:e2221652120.
    PubMed     Abstract available


  137. PIZZIOL V, Demaj X, Di Paolo R, Capraro V, et al
    Political ideology and generosity around the globe.
    Proc Natl Acad Sci U S A. 2023;120:e2219676120.
    PubMed     Abstract available


  138. IZADI A, Hailu A, Godzwon M, Wrighton S, et al
    Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization.
    Proc Natl Acad Sci U S A. 2023;120:e2217590120.
    PubMed     Abstract available


  139. OTTER CJ, Fausto A, Tan LH, Khosla AS, et al
    Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.
    Proc Natl Acad Sci U S A. 2023;120:e2218083120.
    PubMed     Abstract available


    March 2023
  140. ARPINO B, Bordone V, Di Gessa G
    COVID-19 precautionary behaviors and vaccine acceptance among older individuals: The role of close kin.
    Proc Natl Acad Sci U S A. 2023;120:e2214382120.
    PubMed     Abstract available


  141. YANG K, Wang C, Kreutzberger AJB, White KI, et al
    Structure-based design of a SARS-CoV-2 Omicron-specific inhibitor.
    Proc Natl Acad Sci U S A. 2023;120:e2300360120.
    PubMed     Abstract available


  142. HUMBERT M, Olofsson A, Wullimann D, Niessl J, et al
    Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age.
    Proc Natl Acad Sci U S A. 2023;120:e2220320120.
    PubMed     Abstract available


  143. KIM Y, Ryu JY, Kim HU, Lee SY, et al
    Computational prediction of interactions between Paxlovid and prescription drugs.
    Proc Natl Acad Sci U S A. 2023;120:e2221857120.
    PubMed     Abstract available


  144. G MOREIRA T, Gauthier CD, Murphy L, Lanser TB, et al
    Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19.
    Proc Natl Acad Sci U S A. 2023;120:e2220272120.
    PubMed     Abstract available


  145. SAAR KL, McCorkindale W, Fearon D, Boby M, et al
    Turning high-throughput structural biology into predictive inhibitor design.
    Proc Natl Acad Sci U S A. 2023;120:e2214168120.
    PubMed     Abstract available


  146. LIU Z, Zhou J, Wang X, Xu W, et al
    A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
    Proc Natl Acad Sci U S A. 2023;120:e2221713120.
    PubMed     Abstract available


  147. HARIHARAN VN, Shin M, Chang CW, O'Reilly D, et al
    Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2023;120:e2219523120.
    PubMed     Abstract available


  148. MUNOZ-BASAGOITI J, Monteiro FLL, Krumpe LRH, Armario-Najera V, et al
    Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2214561120.
    PubMed     Abstract available


  149. STENSETH NC, Schlatte R, Liu X, Pielke R Jr, et al
    How to avoid a local epidemic becoming a global pandemic.
    Proc Natl Acad Sci U S A. 2023;120:e2220080120.
    PubMed     Abstract available


  150. CUI L, Fang Z, De Souza CM, Lerbs T, et al
    Innate immune cell activation causes lung fibrosis in a humanized model of long COVID.
    Proc Natl Acad Sci U S A. 2023;120:e2217199120.
    PubMed     Abstract available


  151. HE D, Lin L, Artzy-Randrup Y, Demirhan H, et al
    Resolving the enigma of Iquitos and Manaus: A modeling analysis of multiple COVID-19 epidemic waves in two Amazonian cities.
    Proc Natl Acad Sci U S A. 2023;120:e2211422120.
    PubMed     Abstract available


    February 2023
  152. SCHUMM B, Heiber M, Gratz F, Stabile L, et al
    Respiratory aerosol particle emission and simulated infection risk is greater during indoor endurance than resistance exercise.
    Proc Natl Acad Sci U S A. 2023;120:e2220882120.
    PubMed     Abstract available


  153. LEVIN JM, Bukowski LA, Minson JA, Kahn JM, et al
    The political polarization of COVID-19 treatments among physicians and laypeople in the United States.
    Proc Natl Acad Sci U S A. 2023;120:e2216179120.
    PubMed     Abstract available


  154. HEFFETZ O, Rabin M
    Estimating perceptions of the relative COVID risk of different social-distancing behaviors from respondents' pairwise assessments.
    Proc Natl Acad Sci U S A. 2023;120:e2219599120.
    PubMed     Abstract available


  155. CHEN KY, Karuppusamy J, O'Neill MB, Opuu V, et al
    High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing.
    Proc Natl Acad Sci U S A. 2023;120:e2211098120.
    PubMed     Abstract available


  156. CASERTA LC, Martins M, Butt SL, Hollingshead NA, et al
    White-tailed deer (Odocoileus virginianus) may serve as a wildlife reservoir for nearly extinct SARS-CoV-2 variants of concern.
    Proc Natl Acad Sci U S A. 2023;120:e2215067120.
    PubMed     Abstract available


    January 2023
  157. MESNER D, Reuschl AK, Whelan MVX, Bronzovich T, et al
    SARS-CoV-2 evolution influences GBP and IFITM sensitivity.
    Proc Natl Acad Sci U S A. 2023;120:e2212577120.
    PubMed     Abstract available


  158. PRESKA STEINBERG A, Silander OK, Kussell E
    Correlated substitutions reveal SARS-like coronaviruses recombine frequently with a diverse set of structured gene pools.
    Proc Natl Acad Sci U S A. 2023;120:e2206945119.
    PubMed     Abstract available


  159. WANG L, Wang S, Wu L, Li W, et al
    PCIF1-mediated deposition of 5'-cap N(6),2'-O-dimethyladenosine in ACE2 and TMPRSS2 mRNA regulates susceptibility to SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2023;120:e2210361120.
    PubMed     Abstract available


  160. ATHEY S, Grabarz K, Luca M, Wernerfelt N, et al
    Digital public health interventions at scale: The impact of social media advertising on beliefs and outcomes related to COVID vaccines.
    Proc Natl Acad Sci U S A. 2023;120:e2208110120.
    PubMed     Abstract available


  161. LIU D, Chen C, Chen D, Zhu A, et al
    Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2202820120.
    PubMed     Abstract available


  162. LEE DB, Kim H, Jeong JH, Jang US, et al
    Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge.
    Proc Natl Acad Sci U S A. 2023;120:e2208425120.
    PubMed     Abstract available


  163. SONDERGAARD JN, Tulyeu J, Edahiro R, Shirai Y, et al
    A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2023;120:e2217902120.
    PubMed     Abstract available


  164. MANNES PZ, Barnes CE, Biermann J, Latoche JD, et al
    Molecular imaging of chemokine-like receptor 1 (CMKLR1) in experimental acute lung injury.
    Proc Natl Acad Sci U S A. 2023;120:e2216458120.
    PubMed     Abstract available


  165. VOUTOURI C, Hardin CC, Naranbhai V, Nikmaneshi MR, et al
    Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2211132120.
    PubMed     Abstract available


  166. FIRNEISZ G
    Rebound increase in circulating dipeptidyl peptidase 4 (DPP4) enzyme activity after acute COVID-19.
    Proc Natl Acad Sci U S A. 2023;120:e2220067120.
    PubMed    


  167. LIN SH, Yang Z
    Reply to Firneisz: "Rebound increase in circulating dipeptidyl peptidase-4 (DPP4) enzyme activity after acute Covid-19".
    Proc Natl Acad Sci U S A. 2023;120:e2220329120.
    PubMed    


  168. MORITA M, Yoneda A, Tokunoh N, Masaki T, et al
    Upregulation of Robo4 expression by SMAD signaling suppresses vascular permeability and mortality in endotoxemia and COVID-19 models.
    Proc Natl Acad Sci U S A. 2023;120:e2213317120.
    PubMed     Abstract available


  169. GAHBAUER S, Correy GJ, Schuller M, Ferla MP, et al
    Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2212931120.
    PubMed     Abstract available


  170. A HOFFMAN D, Strezhnev A
    Longer trips to court cause evictions.
    Proc Natl Acad Sci U S A. 2023;120:e2210467120.
    PubMed     Abstract available


  171. KRISHNAMOORTHY N, Walker KH, Bruggemann TR, Tavares LP, et al
    The Maresin 1-LGR6 axis decreases respiratory syncytial virus-induced lung inflammation.
    Proc Natl Acad Sci U S A. 2023;120:e2206480120.
    PubMed     Abstract available


  172. BARNETT M, Buchak G, Yannelis C
    Epidemic responses under uncertainty.
    Proc Natl Acad Sci U S A. 2023;120:e2208111120.
    PubMed     Abstract available


  173. ARSHAD N, Laurent-Rolle M, Ahmed WS, Hsu JC, et al
    SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression.
    Proc Natl Acad Sci U S A. 2023;120:e2208525120.
    PubMed     Abstract available


    December 2022
  174. PECETTA S, Rappuoli R
    mRNA, the beginning of a new influenza vaccine game.
    Proc Natl Acad Sci U S A. 2022;119:e2217533119.
    PubMed    


  175. BAKER RE, Saad-Roy CM, Park SW, Farrar J, et al
    Long-term benefits of nonpharmaceutical interventions for endemic infections are shaped by respiratory pathogen dynamics.
    Proc Natl Acad Sci U S A. 2022;119:e2208895119.
    PubMed     Abstract available


  176. SMERDON D
    The effect of masks on cognitive performance.
    Proc Natl Acad Sci U S A. 2022;119:e2206528119.
    PubMed     Abstract available


    November 2022
  177. DU Z, Wang L, Shan S, Lam D, et al
    Pandemic fatigue impedes mitigation of COVID-19 in Hong Kong.
    Proc Natl Acad Sci U S A. 2022;119:e2213313119.
    PubMed     Abstract available


  178. JORGENSEN F, Bor A, Rasmussen MS, Lindholt MF, et al
    Pandemic fatigue fueled political discontent during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2201266119.
    PubMed     Abstract available


  179. KAO KS, Gupta A, Zong G, Li C, et al
    Synthetic nanobodies as tools to distinguish IgG Fc glycoforms.
    Proc Natl Acad Sci U S A. 2022;119:e2212658119.
    PubMed     Abstract available


  180. LIU Q, Miao H, Li S, Zhang P, et al
    Anti-PF4 antibodies associated with disease severity in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2213361119.
    PubMed     Abstract available


  181. BOYLE L, Hletko S, Huang J, Lee J, et al
    Selective sweeps in SARS-CoV-2 variant competition.
    Proc Natl Acad Sci U S A. 2022;119:e2213879119.
    PubMed     Abstract available


  182. HE Q, Xie Y
    The moral filter of patriotic prejudice: How Americans view Chinese in the COVID-19 era.
    Proc Natl Acad Sci U S A. 2022;119:e2212183119.
    PubMed     Abstract available


  183. GARRY RF
    The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade.
    Proc Natl Acad Sci U S A. 2022;119:e2214427119.
    PubMed    


  184. SOLOMON MD, Steinman L, Liu VX
    Reply to Fillmore et al.: Additional evidence of non-SARS-CoV-2 coronavirus cross-immunity.
    Proc Natl Acad Sci U S A. 2022;119:e2215620119.
    PubMed    


  185. FILLMORE NR, Szalat RE, La J, Branch-Elliman W, et al
    Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study.
    Proc Natl Acad Sci U S A. 2022;119:e2213783119.
    PubMed    


  186. SCHIFF ND, Brown EN
    Protective down-regulated states in the human brain: A possible lesson from COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2120221119.
    PubMed     Abstract available


  187. MASSENKOFF M, Chalfin A
    Activity-adjusted crime rates show that public safety worsened in 2020.
    Proc Natl Acad Sci U S A. 2022;119:e2208598119.
    PubMed     Abstract available


  188. CONSTANTINO SM, Cooperman AD, Keohane RO, Weber EU, et al
    Personal hardship narrows the partisan gap in COVID-19 and climate change responses.
    Proc Natl Acad Sci U S A. 2022;119:e2120653119.
    PubMed     Abstract available


  189. MCMAHON M, O'Dell G, Tan J, Sarkozy A, et al
    Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
    Proc Natl Acad Sci U S A. 2022;119:e2206333119.
    PubMed     Abstract available


  190. HARRISON NL, Sachs JD
    Reply to Garry: The origin of SARS-CoV-2 remains unresolved.
    Proc Natl Acad Sci U S A. 2022;119:e2215826119.
    PubMed    


  191. ZHANG W, Shi K, Geng Q, Ye G, et al
    Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant.
    Proc Natl Acad Sci U S A. 2022;119:e2206509119.
    PubMed     Abstract available


  192. GODELLAS NE, Cymes GD, Grosman C
    An experimental test of the nicotinic hypothesis of COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2204242119.
    PubMed     Abstract available


  193. ZHANG P, Philippot Q, Ren W, Lei WT, et al
    Genome-wide detection of human variants that disrupt intronic branchpoints.
    Proc Natl Acad Sci U S A. 2022;119:e2211194119.
    PubMed     Abstract available


    October 2022
  194. PISHESHA N, Harmand T, Carpenet C, Liu X, et al
    Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms.
    Proc Natl Acad Sci U S A. 2022;119:e2211065119.
    PubMed     Abstract available


  195. SMIRNOV O, Hsieh PH
    COVID-19, climate change, and the finite pool of worry in 2019 to 2021 Twitter discussions.
    Proc Natl Acad Sci U S A. 2022;119:e2210988119.
    PubMed     Abstract available


  196. WANG X, Rimal S, Tantray I, Geng J, et al
    Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2-encoded Nsp1.
    Proc Natl Acad Sci U S A. 2022;119:e2202322119.
    PubMed     Abstract available


  197. LI L, Chai Y, Peng W, Li D, et al
    Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel.
    Proc Natl Acad Sci U S A. 2022;119:e2210724119.
    PubMed     Abstract available


  198. KEUSCH GT, Amuasi JH, Anderson DE, Daszak P, et al
    Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses.
    Proc Natl Acad Sci U S A. 2022;119:e2202871119.
    PubMed     Abstract available


  199. ROSU ME, Lexmond P, Bestebroer TM, Hauser BM, et al
    Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B/Victoria and B/Yamagata lineages.
    Proc Natl Acad Sci U S A. 2022;119:e2211616119.
    PubMed     Abstract available


  200. ZHANG F, Zang TM, Stevenson EM, Lei X, et al
    Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.
    Proc Natl Acad Sci U S A. 2022;119:e2209042119.
    PubMed     Abstract available


  201. LU JG, Song LL, Zheng Y, Wang LC, et al
    Masks as a moral symbol: Masks reduce wearers' deviant behavior in China during COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2211144119.
    PubMed     Abstract available


  202. YANG L, Constantino SM, Grenfell BT, Weber EU, et al
    Sociocultural determinants of global mask-wearing behavior.
    Proc Natl Acad Sci U S A. 2022;119:e2213525119.
    PubMed     Abstract available


  203. WATSON-PARRIS D, Christensen MW, Laurenson A, Clewley D, et al
    Shipping regulations lead to large reduction in cloud perturbations.
    Proc Natl Acad Sci U S A. 2022;119:e2206885119.
    PubMed     Abstract available


  204. ASCHMANN HE, Riley AR, Chen R, Chen YH, et al
    Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2210941119.
    PubMed     Abstract available


  205. YANG K, Wang C, Kreutzberger AJB, Ojha R, et al
    Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
    Proc Natl Acad Sci U S A. 2022;119:e2210990119.
    PubMed     Abstract available


  206. GARRY RF
    SARS-CoV-2 furin cleavage site was not engineered.
    Proc Natl Acad Sci U S A. 2022;119:e2211107119.
    PubMed    


    September 2022
  207. CHATURVEDI S, Beutler N, Vasen G, Pablo M, et al
    A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters.
    Proc Natl Acad Sci U S A. 2022;119:e2204624119.
    PubMed     Abstract available


  208. MCDERMOTT A
    Kids adopt different ways of coping in wake of the pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2214564119.
    PubMed    


  209. KREUTZBERGER AJB, Sanyal A, Saminathan A, Bloyet LM, et al
    SARS-CoV-2 requires acidic pH to infect cells.
    Proc Natl Acad Sci U S A. 2022;119:e2209514119.
    PubMed     Abstract available


  210. COHEN JE, Davis RA, Samorodnitsky G
    COVID-19 cases and deaths in the United States follow Taylor's law for heavy-tailed distributions with infinite variance.
    Proc Natl Acad Sci U S A. 2022;119:e2209234119.
    PubMed     Abstract available


  211. VAN SOLINGEN C, Cyr Y, Scacalossi KR, de Vries M, et al
    Long noncoding RNA CHROMR regulates antiviral immunity in humans.
    Proc Natl Acad Sci U S A. 2022;119:e2210321119.
    PubMed     Abstract available


  212. MCGRATH ME, Xue Y, Dillen C, Oldfield L, et al
    SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis.
    Proc Natl Acad Sci U S A. 2022;119:e2204717119.
    PubMed     Abstract available


  213. VAN BEEK M, Nussenzweig MC, Chakraborty AK
    Two complementary features of humoral immune memory confer protection against the same or variant antigens.
    Proc Natl Acad Sci U S A. 2022;119:e2205598119.
    PubMed     Abstract available


  214. ENDO A, Uchida M, Liu Y, Atkins KE, et al
    Simulating respiratory disease transmission within and between classrooms to assess pandemic management strategies at schools.
    Proc Natl Acad Sci U S A. 2022;119:e2203019119.
    PubMed     Abstract available


  215. POPLI S, Chakravarty S, Fan S, Glanz A, et al
    IRF3 inhibits nuclear translocation of NF-kappaB to prevent viral inflammation.
    Proc Natl Acad Sci U S A. 2022;119:e2121385119.
    PubMed     Abstract available


  216. AZNAOUROVA M, Schmerer N, Janga H, Zhang Z, et al
    Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2120680119.
    PubMed     Abstract available


  217. CARLEY S, Graff M, Konisky DM, Memmott T, et al
    Behavioral and financial coping strategies among energy-insecure households.
    Proc Natl Acad Sci U S A. 2022;119:e2205356119.
    PubMed     Abstract available


  218. SHAFFER L
    Lots of long COVID treatment leads, but few are proven.
    Proc Natl Acad Sci U S A. 2022;119:e2213524119.
    PubMed    


    August 2022
  219. CARIOU M, Picard L, Gueguen L, Jacquet S, et al
    Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2206610119.
    PubMed     Abstract available


  220. CRUNFLI F, Carregari VC, Veras FP, Silva LS, et al
    Morphological, cellular, and molecular basis of brain infection in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2022;119:e2200960119.
    PubMed     Abstract available


  221. ABURTO JM, Tilstra AM, Floridi G, Dowd JB, et al
    Significant impacts of the COVID-19 pandemic on race/ethnic differences in US mortality.
    Proc Natl Acad Sci U S A. 2022;119:e2205813119.
    PubMed     Abstract available


  222. LU M, Chamblee M, Zhang Y, Ye C, et al
    SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.
    Proc Natl Acad Sci U S A. 2022;119:e2110105119.
    PubMed     Abstract available


  223. CHANDRA S
    Data analysis of viral complementary DNA/RNA sequences for low-frequency intrahost-single nucleotide variants in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2205269119.
    PubMed    


  224. BASHOR L, Gagne RB, Bosco-Lauth A, Bowen RA, et al
    Reply to Chandra: Severe Acute Respiratory Syndrome-Coronavirus-2 variant analysis reveals within-host selection of intra-host single nucleotide variants.
    Proc Natl Acad Sci U S A. 2022;119:e2206919119.
    PubMed    


  225. JOSEPH M, Wu Y, Dannebaum R, Rubelt F, et al
    Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2201541119.
    PubMed     Abstract available


  226. YANG Z, Wu D, Lu S, Qiu Y, et al
    Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients.
    Proc Natl Acad Sci U S A. 2022;119:e2117089119.
    PubMed     Abstract available


  227. XIONG H, Sun H, Wang S, Yuan L, et al
    The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204256119.
    PubMed     Abstract available


  228. MENG F, Yang H, Qu Z, Chen Y, et al
    A Eurasian avian-like H1N1 swine influenza reassortant virus became pathogenic and highly transmissible due to mutations in its PA gene.
    Proc Natl Acad Sci U S A. 2022;119:e2203919119.
    PubMed     Abstract available


  229. CHEN J, Ye Z, Huang C, Qiu M, et al
    Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response.
    Proc Natl Acad Sci U S A. 2022;119:e2207841119.
    PubMed     Abstract available


  230. WANG X, Du Z, James E, Fox SJ, et al
    The effectiveness of COVID-19 testing and contact tracing in a US city.
    Proc Natl Acad Sci U S A. 2022;119:e2200652119.
    PubMed     Abstract available


  231. BANKER M, Miller M, Voichek G, Goor D, et al
    Prosocial nudges and visual indicators increase social distancing, but authoritative nudges do not.
    Proc Natl Acad Sci U S A. 2022;119:e2116156119.
    PubMed     Abstract available


  232. ZHANG Y, Lu M, Mahesh KC, Kim E, et al
    A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2022;119:e2201616119.
    PubMed     Abstract available


  233. IWAMURA C, Hirahara K, Kiuchi M, Ikehara S, et al
    Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity.
    Proc Natl Acad Sci U S A. 2022;119:e2203437119.
    PubMed     Abstract available


  234. SOLOMON MD, Escobar GJ, Lu Y, Schlessinger D, et al
    Risk of severe COVID-19 infection among adults with prior exposure to children.
    Proc Natl Acad Sci U S A. 2022;119:e2204141119.
    PubMed     Abstract available


  235. GARCIA-MORO E, Zhang J, Calder LJ, Brown NR, et al
    Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH.
    Proc Natl Acad Sci U S A. 2022;119:e2208011119.
    PubMed     Abstract available


  236. NOONE DP, Dijkstra DJ, van der Klugt TT, van Veelen PA, et al
    PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation.
    Proc Natl Acad Sci U S A. 2022;119:e2208144119.
    PubMed     Abstract available


  237. LI W, Wang Q, Liu Y, Small ML, et al
    A spatiotemporal decay model of human mobility when facing large-scale crises.
    Proc Natl Acad Sci U S A. 2022;119:e2203042119.
    PubMed     Abstract available


  238. VU MN, Lokugamage KG, Plante JA, Scharton D, et al
    QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.
    Proc Natl Acad Sci U S A. 2022;119:e2205690119.
    PubMed     Abstract available


  239. XU Z, Choi JH, Dai DL, Luo J, et al
    SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation.
    Proc Natl Acad Sci U S A. 2022;119:e2204539119.
    PubMed     Abstract available


  240. GUO K, Barrett BS, Morrison JH, Mickens KL, et al
    Interferon resistance of emerging SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2022;119:e2203760119.
    PubMed     Abstract available


  241. KRYMOVA E, Bejar B, Thanou D, Sun T, et al
    Trend estimation and short-term forecasting of COVID-19 cases and deaths worldwide.
    Proc Natl Acad Sci U S A. 2022;119:e2112656119.
    PubMed     Abstract available


  242. GAMBETTA D, Morisi D
    COVID-19 infection induces higher trust in strangers.
    Proc Natl Acad Sci U S A. 2022;119:e2116818119.
    PubMed     Abstract available


  243. LUO G, Zhang J, Lin L, Mignot EJ, et al
    Characterization of T cell receptors reactive to HCRTNH2, pHA273-287, and NP17-31 in control and narcolepsy patients.
    Proc Natl Acad Sci U S A. 2022;119:e2205797119.
    PubMed     Abstract available


  244. MELIN JL, Correll SJ
    Preventing soft skill decay among early-career women in STEM during COVID-19: Evidence from a longitudinal intervention.
    Proc Natl Acad Sci U S A. 2022;119:e2123105119.
    PubMed     Abstract available


  245. SYED AM, Ciling A, Taha TY, Chen IP, et al
    Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.
    Proc Natl Acad Sci U S A. 2022;119:e2200592119.
    PubMed     Abstract available


  246. MIKOLAJEK H, Weckener M, Brotzakis ZF, Huo J, et al
    Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes.
    Proc Natl Acad Sci U S A. 2022;119:e2205412119.
    PubMed     Abstract available


  247. TOWNSEND JP, Hassler HB, Sah P, Galvani AP, et al
    The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204336119.
    PubMed     Abstract available


    July 2022
  248. HUANG S, Fishell G
    In SARS-CoV-2, astrocytes are in it for the long haul.
    Proc Natl Acad Sci U S A. 2022;119:e2209130119.
    PubMed    


  249. MARTNER A, Grauers Wiktorin H, Tornell A, Ringlander J, et al
    Transient and durable T cell reactivity after COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2203659119.
    PubMed     Abstract available


  250. LIU Q, Wang H, Zhang H, Sui L, et al
    The global succinylation of SARS-CoV-2-infected host cells reveals drug targets.
    Proc Natl Acad Sci U S A. 2022;119:e2123065119.
    PubMed     Abstract available


  251. ANDREWS MG, Mukhtar T, Eze UC, Simoneau CR, et al
    Tropism of SARS-CoV-2 for human cortical astrocytes.
    Proc Natl Acad Sci U S A. 2022;119:e2122236119.
    PubMed     Abstract available


  252. YUAN M, Zhu X, He WT, Zhou P, et al
    A broad and potent neutralization epitope in SARS-related coronaviruses.
    Proc Natl Acad Sci U S A. 2022;119:e2205784119.
    PubMed     Abstract available


  253. FISMAN D
    Universal healthcare and the pandemic mortality gap.
    Proc Natl Acad Sci U S A. 2022;119:e2208032119.
    PubMed    


  254. LONDAHL J, Alsved M
    Abrupt decreases in infectivity of SARS-CoV-2 in aerosols.
    Proc Natl Acad Sci U S A. 2022;119:e2208742119.
    PubMed    


  255. RABB N, Bowers J, Glick D, Wilson KH, et al
    The influence of social norms varies with "others" groups: Evidence from COVID-19 vaccination intentions.
    Proc Natl Acad Sci U S A. 2022;119:e2118770119.
    PubMed     Abstract available


  256. MAHAS A, Marsic T, Lopez-Portillo Masson M, Wang Q, et al
    Characterization of a thermostable Cas13 enzyme for one-pot detection of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2118260119.
    PubMed     Abstract available


  257. BAN DK, Bodily T, Karkisaval AG, Dong Y, et al
    Rapid self-test of unprocessed viruses of SARS-CoV-2 and its variants in saliva by portable wireless graphene biosensor.
    Proc Natl Acad Sci U S A. 2022;119:e2206521119.
    PubMed     Abstract available


  258. KARDAVA L, Rachmaninoff N, Lau WW, Buckner CM, et al
    Early human B cell signatures of the primary antibody response to mRNA vaccination.
    Proc Natl Acad Sci U S A. 2022;119:e2204607119.
    PubMed     Abstract available


  259. BEUCHER G, Blondot ML, Celle A, Pied N, et al
    Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction.
    Proc Natl Acad Sci U S A. 2022;119:e2202370119.
    PubMed     Abstract available


  260. KAPOOR K, Chen T, Tajkhorshid E
    Posttranslational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors.
    Proc Natl Acad Sci U S A. 2022;119:e2119761119.
    PubMed     Abstract available


  261. IOANNIDIS JPA, Bendavid E, Salholz-Hillel M, Boyack KW, et al
    Massive covidization of research citations and the citation elite.
    Proc Natl Acad Sci U S A. 2022;119:e2204074119.
    PubMed     Abstract available


  262. IOB E, Steptoe A, Zaninotto P
    Mental health, financial, and social outcomes among older adults with probable COVID-19 infection: A longitudinal cohort study.
    Proc Natl Acad Sci U S A. 2022;119:e2200816119.
    PubMed     Abstract available


  263. OSWIN HP, Haddrell AE, Otero-Fernandez M, Mann JFS, et al
    The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment.
    Proc Natl Acad Sci U S A. 2022;119:e2200109119.
    PubMed     Abstract available


  264. HU G, Hamovit N, Croft K, Roberts JD, et al
    Assessing inequities underlying racial disparities of COVID-19 mortality in Louisiana parishes.
    Proc Natl Acad Sci U S A. 2022;119:e2123533119.
    PubMed     Abstract available


    June 2022
  265. ALETA A, Martin-Corral D, Bakker MA, Pastore Y Piontti A, et al
    Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas.
    Proc Natl Acad Sci U S A. 2022;119:e2112182119.
    PubMed     Abstract available


  266. DIEDERICHS M, van Ewijk R, Isphording IE, Pestel N, et al
    Schools under mandatory testing can mitigate the spread of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2201724119.
    PubMed     Abstract available


  267. HU M, Qiu Z, Bi Z, Tian T, et al
    Photocontrolled crRNA activation enables robust CRISPR-Cas12a diagnostics.
    Proc Natl Acad Sci U S A. 2022;119:e2202034119.
    PubMed     Abstract available


  268. SHEN Y, Courtney JM, Anfinrud P, Bax A, et al
    Hybrid measurement of respiratory aerosol reveals a dominant coarse fraction resulting from speech that remains airborne for minutes.
    Proc Natl Acad Sci U S A. 2022;119:e2203086119.
    PubMed     Abstract available


  269. QIN C, Rao Y, Yuan H, Wang TY, et al
    SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis.
    Proc Natl Acad Sci U S A. 2022;119:e2122897119.
    PubMed     Abstract available


  270. SNYDER M, Alburez-Gutierrez D, Williams I, Zagheni E, et al
    Estimates from 31 countries show the significant impact of COVID-19 excess mortality on the incidence of family bereavement.
    Proc Natl Acad Sci U S A. 2022;119:e2202686119.
    PubMed     Abstract available


  271. ANAHTAR M, Chan LW, Ko H, Rao A, et al
    Host protease activity classifies pneumonia etiology.
    Proc Natl Acad Sci U S A. 2022;119:e2121778119.
    PubMed     Abstract available


  272. GALVANI AP, Parpia AS, Pandey A, Sah P, et al
    Universal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2200536119.
    PubMed     Abstract available


  273. SIMONETTI B, Daly JL, Simon-Gracia L, Klein K, et al
    ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.
    Proc Natl Acad Sci U S A. 2022;119:e2201980119.
    PubMed     Abstract available


  274. LIMA DE MIRANDA K, Snower DJ
    The societal responses to COVID-19: Evidence from the G7 countries.
    Proc Natl Acad Sci U S A. 2022;119:e2117155119.
    PubMed     Abstract available


  275. AMERICO JL, Cotter CA, Earl PL, Liu R, et al
    Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119:e2202069119.
    PubMed     Abstract available


  276. ENGELBERT BAIN L, Berner-Rodoreda A, McMahon SA, Sarker M, et al
    One lesson of COVID-19: Conduct more health policy trials.
    Proc Natl Acad Sci U S A. 2022;119:e2119887119.
    PubMed    


  277. LEECH G, Rogers-Smith C, Monrad JT, Sandbrink JB, et al
    Mask wearing in community settings reduces SARS-CoV-2 transmission.
    Proc Natl Acad Sci U S A. 2022;119:e2119266119.
    PubMed     Abstract available


    May 2022
  278. HEKMATI A, Luhar M, Krishnamachari B, Mataric M, et al
    Simulating COVID-19 classroom transmission on a university campus.
    Proc Natl Acad Sci U S A. 2022;119:e2116165119.
    PubMed     Abstract available


  279. MUTSCH B, Heiber M, Gratz F, Hain R, et al
    Aerosol particle emission increases exponentially above moderate exercise intensity resulting in superemission during maximal exercise.
    Proc Natl Acad Sci U S A. 2022;119:e2202521119.
    PubMed     Abstract available



  280. A global experiment on motivating social distancing during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2111091119.
    PubMed     Abstract available


  281. ZHU X, Han J, Sun W, Puente-Massaguer E, et al
    Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.
    Proc Natl Acad Sci U S A. 2022;119:e2200821119.
    PubMed     Abstract available


  282. BAXTER-KING R, Brown JR, Enos RD, Naeim A, et al
    How local partisan context conditions prosocial behaviors: Mask wearing during COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2116311119.
    PubMed     Abstract available


  283. ZHANG C, Verma A, Feng Y, Melo MCR, et al
    Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119:e2123000119.
    PubMed     Abstract available


  284. MANRY J, Bastard P, Gervais A, Le Voyer T, et al
    The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
    Proc Natl Acad Sci U S A. 2022;119:e2200413119.
    PubMed     Abstract available


  285. COMAR CE, Otter CJ, Pfannenstiel J, Doerger E, et al
    MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.
    Proc Natl Acad Sci U S A. 2022;119:e2123208119.
    PubMed     Abstract available


  286. ELTOBGY MM, Zani A, Kenney AD, Estfanous S, et al
    Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis.
    Proc Natl Acad Sci U S A. 2022;119:e2202012119.
    PubMed     Abstract available


  287. HARRISON NL, Sachs JD
    A call for an independent inquiry into the origin of the SARS-CoV-2 virus.
    Proc Natl Acad Sci U S A. 2022;119:e2202769119.
    PubMed    


  288. KINGSTAD-BAKKE B, Lee W, Chandrasekar SS, Gasper DJ, et al
    Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.
    Proc Natl Acad Sci U S A. 2022;119:e2118312119.
    PubMed     Abstract available


  289. TORRES JL, Ozorowski G, Andreano E, Liu H, et al
    Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody.
    Proc Natl Acad Sci U S A. 2022;119:e2120976119.
    PubMed     Abstract available


  290. SUKHWAL PC, Kankanhalli A
    Determining containment policy impacts on public sentiment during the pandemic using social media data.
    Proc Natl Acad Sci U S A. 2022;119:e2117292119.
    PubMed     Abstract available


  291. SPRECO A, Schon T, Timpka T
    Corruption should be taken into account when considering COVID-19 vaccine allocation.
    Proc Natl Acad Sci U S A. 2022;119:e2122664119.
    PubMed    


  292. DUCH R, Robinson TS, Clarke PM, Roope LSJ, et al
    Reply to Spreco et al.: Perceived corruption and preferences for COVID-19 vaccine allocations.
    Proc Natl Acad Sci U S A. 2022;119:e2201847119.
    PubMed    


  293. HONG J, Kwon HJ, Cachau R, Chen CZ, et al
    Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2022;119:e2201433119.
    PubMed     Abstract available


  294. PAIREAU J, Andronico A, Hoze N, Layan M, et al
    An ensemble model based on early predictors to forecast COVID-19 health care demand in France.
    Proc Natl Acad Sci U S A. 2022;119:e2103302119.
    PubMed     Abstract available


  295. LEE YY, Cal-Kayitmazbatir S, Francey LJ, Bahiru MS, et al
    duper is a null mutation of Cryptochrome 1 in Syrian hamsters.
    Proc Natl Acad Sci U S A. 2022;119:e2123560119.
    PubMed     Abstract available


  296. HALL GJ, Sargent TJ
    Three world wars: Fiscal-monetary consequences.
    Proc Natl Acad Sci U S A. 2022;119:e2200349119.
    PubMed     Abstract available


    April 2022
  297. VICENS Q, Kieft JS
    Thoughts on how to think (and talk) about RNA structure.
    Proc Natl Acad Sci U S A. 2022;119:e2112677119.
    PubMed     Abstract available


  298. ZHAO Y, Zhu Y, Liu X, Jin Z, et al
    Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2117142119.
    PubMed     Abstract available


  299. YANG K, Wang C, White KI, Pfuetzner RA, et al
    Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle.
    Proc Natl Acad Sci U S A. 2022;119:e2119467119.
    PubMed     Abstract available


  300. MORRISON CB, Edwards CE, Shaffer KM, Araba KC, et al
    SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13.
    Proc Natl Acad Sci U S A. 2022;119:e2119680119.
    PubMed     Abstract available


  301. CRAMER EY, Ray EL, Lopez VK, Bracher J, et al
    Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States.
    Proc Natl Acad Sci U S A. 2022;119:e2113561119.
    PubMed     Abstract available


  302. ROBINSON PC, Liew DFL, Tanner HL, Grainger JR, et al
    COVID-19 therapeutics: Challenges and directions for the future.
    Proc Natl Acad Sci U S A. 2022;119:e2119893119.
    PubMed     Abstract available


  303. SUN Z, Wang L, Li X, Fan C, et al
    An extended conformation of SARS-CoV-2 main protease reveals allosteric targets.
    Proc Natl Acad Sci U S A. 2022;119:e2120913119.
    PubMed     Abstract available


  304. GARCIA BULLE B, Shen D, Shah D, Hosoi AE, et al
    Public health implications of opening National Football League stadiums during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2114226119.
    PubMed     Abstract available


  305. BAUER MS, Gruber S, Hausch A, Gomes PSFC, et al
    A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.
    Proc Natl Acad Sci U S A. 2022;119:e2114397119.
    PubMed     Abstract available


  306. TEPLENSKY MH, Distler ME, Kusmierz CD, Evangelopoulos M, et al
    Spherical nucleic acids as an infectious disease vaccine platform.
    Proc Natl Acad Sci U S A. 2022;119:e2119093119.
    PubMed     Abstract available


    March 2022
  307. KAVISHNA R, Kang TY, Vacca M, Chua BYL, et al
    A single-shot vaccine approach for the universal influenza A vaccine candidate M2e.
    Proc Natl Acad Sci U S A. 2022;119:e2025607119.
    PubMed     Abstract available


  308. SCHMELZ K, Bowles S
    Opposition to voluntary and mandated COVID-19 vaccination as a dynamic process: Evidence and policy implications of changing beliefs.
    Proc Natl Acad Sci U S A. 2022;119:e2118721119.
    PubMed     Abstract available


  309. PEEPLES L
    Understanding Kids and COVID.
    Proc Natl Acad Sci U S A. 2022;119:e2203753119.
    PubMed    


  310. THOMAS LJ, Huang P, Yin F, Xu J, et al
    Geographical patterns of social cohesion drive disparities in early COVID infection hazard.
    Proc Natl Acad Sci U S A. 2022;119:e2121675119.
    PubMed     Abstract available


  311. LEWNARD JA, Fries LF, Cho I, Chen J, et al
    Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 2022;119:e2112410119.
    PubMed     Abstract available


  312. GALBRAITH MD, Kinning KT, Sullivan KD, Araya P, et al
    Specialized interferon action in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  313. SHAN S, Luo S, Yang Z, Hong J, et al
    Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization.
    Proc Natl Acad Sci U S A. 2022;119:e2122954119.
    PubMed     Abstract available


  314. GEHLHAUSEN JR, Little AJ, Ko CJ, Emmenegger M, et al
    Lack of association between pandemic chilblains and SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  315. ZEBERG H
    The major genetic risk factor for severe COVID-19 is associated with protection against HIV.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  316. MOELLER NH, Shi K, Demir O, Belica C, et al
    Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    February 2022
  317. DEVARAJAN P, Vong AM, Castonguay CH, Kugler-Umana O, et al
    Strong influenza-induced TFH generation requires CD4 effectors to recognize antigen locally and receive signals from continuing infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  318. BARMAN TK, Huber VC, Bonin JL, Califano D, et al
    Viral PB1-F2 and host IFN-gamma guide ILC2 and T cell activity during influenza virus infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  319. WIECEK W, Ahuja A, Chaudhuri E, Kremer M, et al
    Testing fractional doses of COVID-19 vaccines.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  320. SCHUHENN J, Meister TL, Todt D, Bracht T, et al
    Differential interferon-alpha subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  321. PANDEY P, Al Rumaih Z, Kels MJT, Ng E, et al
    Targeting ectromelia virus and TNF/NF-kappaB or STAT3 signaling for effective treatment of viral pneumonia.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  322. DI SERIO C, Cippa P, Ceschi A, Ferrari P, et al
    Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experience.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


  323. FOX SJ, Lachmann M, Tec M, Pasco R, et al
    Real-time pandemic surveillance using hospital admissions and mobility data.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  324. GOLDRICK-RAB S, Coca V, Gill J, Peele M, et al
    Self-reported COVID-19 infection and implications for mental health and food insecurity among American college students.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  325. KUCHIPUDI SV, Surendran-Nair M, Ruden RM, Yon M, et al
    Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  326. SHI Y, Zeida A, Edwards CE, Mallory ML, et al
    Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  327. RINGLANDER J, Fingal J, Kann H, Prakash K, et al
    Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  328. MILDER FJ, Jongeneelen M, Ritschel T, Bouchier P, et al
    Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  329. PANDEY JP
    IgG3 constant region GM (gamma marker) allotypes could influence the neutralizing potency of anti-SARS-CoV-2 monoclonal antibodies.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


  330. MILKMAN KL, Gandhi L, Patel MS, Graci HN, et al
    A 680,000-person megastudy of nudges to encourage vaccination in pharmacies.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  331. PALACIOS J, Fan Y, Yoeli E, Wang J, et al
    Encouraging the resumption of economic activity after COVID-19: Evidence from a large scale-field experiment in China.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  332. DESPRES HW, Mills MG, Shirley DJ, Schmidt MM, et al
    Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  333. BEANS C
    Researchers getting closer to a "universal" flu vaccine.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


    January 2022
  334. ROSENKRANTZ DJ, Vullikanti A, Ravi SS, Stearns RE, et al
    Fundamental limitations on efficiently forecasting certain epidemic measures in network models.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  335. CHANG KC, Hobbs WR, Roberts ME, Steinert-Threlkeld ZC, et al
    COVID-19 increased censorship circumvention and access to sensitive topics in China.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  336. YANG B, Jia Y, Meng Y, Xue Y, et al
    SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  337. RODRIGUEZ-RIVAS J, Croce G, Muscat M, Weigt M, et al
    Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  338. CHOI VK, Shrestha S, Pan X, Gelfand MJ, et al
    When danger strikes: A linguistic tool for tracking America's collective response to threats.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  339. HUYNH E, Olinger A, Woolley D, Kohli RK, et al
    Evidence for a semisolid phase state of aerosols and droplets relevant to the airborne and surface survival of pathogens.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  340. FLORES A, Cole JC, Dickert S, Eom K, et al
    Politicians polarize and experts depolarize public support for COVID-19 management policies across countries.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  341. GANDON S, Lion S
    Targeted vaccination and the speed of SARS-CoV-2 adaptation.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  342. HUPERT N, Marin-Hernandez D, Gao B, Aguas R, et al
    Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  343. AUGENBLICK N, Kolstad J, Obermeyer Z, Wang A, et al
    Pooled testing efficiency increases with test frequency.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  344. FRAZIER PI, Cashore JM, Duan N, Henderson SG, et al
    Modeling for COVID-19 college reopening decisions: Cornell, a case study.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  345. ZENG C, Evans JP, King T, Zheng YM, et al
    SARS-CoV-2 spreads through cell-to-cell transmission.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  346. YU S, Zheng X, Zhou B, Li J, et al
    SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  347. LEON J, Michelson DA, Olejnik J, Chowdhary K, et al
    A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    December 2021
  348. PAWLICA P, Yario TA, White S, Wang J, et al
    SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  349. JAMIESON KH, Romer D, Jamieson PE, Winneg KM, et al
    The role of non-COVID-specific and COVID-specific factors in predicting a shift in willingness to vaccinate: A panel study.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  350. CHANDRAN V, Bermudez ML, Koka M, Chandran B, et al
    Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  351. ASTLEY CM, Tuli G, Mc Cord KA, Cohn EL, et al
    Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  352. SALOMON JA, Reinhart A, Bilinski A, Chua EJ, et al
    The US COVID-19 Trends and Impact Survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  353. MCDONALD DJ, Bien J, Green A, Hu AJ, et al
    Can auxiliary indicators improve COVID-19 forecasting and hotspot prediction?
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  354. REINHART A, Brooks L, Jahja M, Rumack A, et al
    An open repository of real-time COVID-19 indicators.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  355. NAIR P
    QnAs with Katalin Kariko.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  356. ROSENFELD R, Tibshirani RJ
    Epidemic tracking and forecasting: Lessons learned from a tumultuous year.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  357. LIU X, Luongo C, Matsuoka Y, Park HS, et al
    A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  358. ALVAREZ L, Colom M, Morel JD, Morel JM, et al
    Computing the daily reproduction number of COVID-19 by inverting the renewal equation using a variational technique.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  359. CHEN J, Fan J, Chen Z, Zhang M, et al
    Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  360. WATERLOW NR, van Leeuwen E, Davies NG, Flasche S, et al
    How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  361. BAGHERI G, Thiede B, Hejazi B, Schlenczek O, et al
    An upper bound on one-to-one exposure to infectious human respiratory particles.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  362. KE R, Zitzmann C, Ho DD, Ribeiro RM, et al
    In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  363. BOKEMPER SE, Gerber AS, Omer SB, Huber GA, et al
    Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    November 2021
  364. PENG Y, Wu P, Schartup AT, Zhang Y, et al
    Plastic waste release caused by COVID-19 and its fate in the global ocean.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  365. CHANDLER JC, Bevins SN, Ellis JW, Linder TJ, et al
    SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  366. BANKS MA
    Core Concept: In the wake of COVID-19, decentralized clinical trials move to center stage.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  367. ENDO A, Uchida M, Hayashi N, Liu Y, et al
    Within and between classroom transmission patterns of seasonal influenza among primary school students in Matsumoto city, Japan.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  368. PAN K, Chiu Y, Huang E, Chen M, et al
    Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  369. LAUGHNER JL, Neu JL, Schimel D, Wennberg PO, et al
    Societal shifts due to COVID-19 reveal large-scale complexities and feedbacks between atmospheric chemistry and climate change.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  370. TERRIER C, Chen DL, Sutter M
    COVID-19 within families amplifies the prosociality gap between adolescents of high and low socioeconomic status.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  371. LOPEZ N, Del Debbio L, Baaden M, Praprotnik M, et al
    Lessons learned from urgent computing in Europe: Tackling the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  372. BALISTRERI G, Yamauchi Y, Teesalu T
    A widespread viral entry mechanism: The C-end Rule motif-neuropilin receptor interaction.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  373. PEDERSON T
    A layperson encounter, on the "modified" RNA world.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  374. XIA D, Jin R, Byagathvalli G, Yu H, et al
    An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  375. LEVY R, Zhang P, Bastard P, Dorgham K, et al
    Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  376. SAMET JM, Burke TA, Lakdawala SS, Lowe JJ, et al
    SARS-CoV-2 indoor air transmission is a threat that can be addressed with science.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  377. PISHESHA N, Harmand TJ, Rothlauf PW, Praest P, et al
    A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  378. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reply to Briggs et al.: Genomic integration and expression of SARS-CoV-2 sequences can explain prolonged or recurrent viral RNA detection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  379. BRIGGS E, Ward W, Rey S, Law D, et al
    Assessment of potential SARS-CoV-2 virus integration into human genome reveals no significant impact on RT-qPCR COVID-19 testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  380. SUN L, Kallolimath S, Palt R, Stiasny K, et al
    Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  381. BASHOR L, Gagne RB, Bosco-Lauth AM, Bowen RA, et al
    SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    October 2021
  382. MAHONEY M, Damalanka VC, Tartell MA, Chung DH, et al
    A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  383. RAY D, Le L, Andricioaei I
    Distant residues modulate conformational opening in SARS-CoV-2 spike protein.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  384. LU L, Anderson B, Ha R, D'Agostino A, et al
    A language-matching model to improve equity and efficiency of COVID-19 contact tracing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  385. HUGHES MT, Auwaerter PG, Ehmann MR, Garibaldi BT, et al
    Opinion: The importance of offering vaccine choice in the fight against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  386. POULTER B, Freeborn PH, Jolly WM, Varner JM, et al
    COVID-19 lockdowns drive decline in active fires in southeastern United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  387. URANO E, Okamura T, Ono C, Ueno S, et al
    COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  388. LIU X, Verma A, Garcia G Jr, Ramage H, et al
    Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  389. CHERNOZHUKOV V, Kasahara H, Schrimpf P
    The association of opening K-12 schools with the spread of COVID-19 in the United States: County-level panel data analysis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  390. TEODORESCU K, Plonsky O, Ayal S, Barkan R, et al
    Frequency of enforcement is more important than the severity of punishment in reducing violation behaviors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  391. HENSEN L, Nguyen THO, Rowntree LC, Damelang T, et al
    Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  392. YE C, Chiem K, Park JG, Silvas JA, et al
    Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  393. FISCHER JB, Kobayashi Frisk L, Scholkmann F, Delgado-Mederos R, et al
    Cerebral and systemic physiological effects of wearing face masks in young adults.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  394. WU X, Rapoport TA
    Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  395. ODOR G, Czifra D, Komjathy J, Lovasz L, et al
    Switchover phenomenon induced by epidemic seeding on geometric networks.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  396. VELU C, Iyer S
    Learning from near misses from COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  397. LOURDA M, Dzidic M, Hertwig L, Bergsten H, et al
    High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  398. MCKEOWN B, Poerio GL, Strawson WH, Martinon LM, et al
    The impact of social isolation and changes in work patterns on ongoing thought during the first COVID-19 lockdown in the United Kingdom.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  399. ALGAN Y, Cohen D, Davoine E, Foucault M, et al
    Trust in scientists in times of pandemic: Panel evidence from 12 countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  400. KALLOLIMATH S, Sun L, Palt R, Stiasny K, et al
    Highly active engineered IgG3 antibodies against SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    September 2021
  401. GOLDMAN E
    How the unvaccinated threaten the vaccinated for COVID-19: A Darwinian perspective.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  402. ANDERSON DE, Cui J, Ye Q, Huang B, et al
    Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  403. CRONIN CJ, Evans WN
    Excess mortality from COVID and non-COVID causes in minority populations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  404. JIN W, Stokes JM, Eastman RT, Itkin Z, et al
    Deep learning identifies synergistic drug combinations for treating COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  405. MCGEE RS, Homburger JR, Williams HE, Bergstrom CT, et al
    Model-driven mitigation measures for reopening schools during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  406. DIEKMANN O, Othmer HG, Planque R, Bootsma MCJ, et al
    The discrete-time Kermack-McKendrick model: A versatile and computationally attractive framework for modeling epidemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  407. ROSSMANN L, Bagola K, Stephen T, Gerards AL, et al
    Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  408. MELVIN WJ, Audu CO, Davis FM, Sharma SB, et al
    Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  409. KING HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, et al
    Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  410. DALVIE NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, et al
    Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  411. DUCH R, Roope LSJ, Violato M, Fuentes Becerra M, et al
    Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  412. FISMAN DN, Tuite AR
    Asymptomatic infection is the pandemic's dark matter.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  413. GALVAN-PENA S, Leon J, Chowdhary K, Michelson DA, et al
    Profound Treg perturbations correlate with COVID-19 severity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  414. WANG J, Alipour M, Soligo G, Roccon A, et al
    Short-range exposure to airborne virus transmission and current guidelines.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  415. PROTO E, Zhang A
    COVID-19 and mental health of individuals with different personalities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  416. PORTER E, Wood TJ
    The global effectiveness of fact-checking: Evidence from simultaneous experiments in Argentina, Nigeria, South Africa, and the United Kingdom.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  417. CHAMAKURI S, Lu S, Ucisik MN, Bohren KM, et al
    DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M(pro) inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  418. ANDREANO E, Piccini G, Licastro D, Casalino L, et al
    SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  419. KLUVER H, Hartmann F, Humphreys M, Geissler F, et al
    Incentives can spur COVID-19 vaccination uptake.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  420. MIRABELLI C, Wotring JW, Zhang CJ, McCarty SM, et al
    Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  421. MAZEL-SANCHEZ B, Iwaszkiewicz J, Bonifacio JPP, Silva F, et al
    Influenza A viruses balance ER stress with host protein synthesis shutoff.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  422. LI Z, Liu R, Zhan CG, Wang X, et al
    Reply to Behnam and Klein: Potential role of the His-tag in C-terminal His-tagged SARS-CoV-2 main protease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  423. BEHNAM MAM, Klein CD
    Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  424. HEUVELINE P
    The COVID-19 pandemic adds another 200,000 deaths (50%) to the annual toll of excess mortality in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  425. BROWN RA
    A simple model for control of COVID-19 infections on an urban campus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  426. AASSVE A, Cavalli N, Mencarini L, Plach S, et al
    Early assessment of the relationship between the COVID-19 pandemic and births in high-income countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  427. LU Y, Kaushal N, Huang X, Gaddis SM, et al
    Priming COVID-19 salience increases prejudice and discriminatory intent against Asians and Hispanics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    August 2021
  428. SILVA PJS, Sagastizabal C, Nonato LG, Struchiner CJ, et al
    Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  429. CARTER JG, Orueta Iturbe L, Duprey JHA, Carter IR, et al
    Ultrarapid detection of SARS-CoV-2 RNA using a reverse transcription-free exponential amplification reaction, RTF-EXPAR.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  430. MARANI M, Katul GG, Pan WK, Parolari AJ, et al
    Intensity and frequency of extreme novel epidemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  431. SULLIVAN O, Gershuny J, Sevilla A, Foliano F, et al
    Using time-use diaries to track changing behavior across successive stages of COVID-19 social restrictions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  432. KIM E, Attia Z, Woodfint RM, Zeng C, et al
    Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  433. SAH P, Fitzpatrick MC, Zimmer CF, Abdollahi E, et al
    Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  434. KAUGARS K, Dardick J, de Oliveira AP, Weiss KA, et al
    A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  435. RAMAN G, Peng JC
    Electricity consumption of Singaporean households reveals proactive community response to COVID-19 progression.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  436. GILLES S, Traidl-Hoffmann C, Damialis A
    Reply to Betsch and Sprengholz: Higher SARS-CoV-2 infection numbers related to more airborne pollen, regardless of testing frequency.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  437. BETSCH C, Sprengholz P
    The human factor between airborne pollen concentrations and COVID-19 disease dynamics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  438. AGUILAR E, Roberts NJ, Uluturk I, Kaminski P, et al
    Adaptive staffing can mitigate essential worker disease and absenteeism in an emerging epidemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  439. PAUL BD, Lemle MD, Komaroff AL, Snyder SH, et al
    Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  440. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Response to Parry et al.: Strong evidence for genomic integration of SARS-CoV-2 sequences and expression in patient tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  441. PARRY R, Gifford RJ, Lytras S, Ray SC, et al
    No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  442. AGARWAL R, Dugas M, Ramaprasad J, Luo J, et al
    Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  443. FETZER T, Graeber T
    Measuring the scientific effectiveness of contact tracing: Evidence from a natural experiment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  444. XING X, Xiong Y, Yang R, Wang R, et al
    Predicting the effect of confinement on the COVID-19 spread using machine learning enriched with satellite air pollution observations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  445. ASHWORTH M, Thunstrom L, Cherry TL, Newbold SC, et al
    Emphasize personal health benefits to boost COVID-19 vaccination rates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  446. PINK SL, Chu J, Druckman JN, Rand DG, et al
    Elite party cues increase vaccination intentions among Republicans.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  447. BAKER A, Biazzo I, Braunstein A, Catania G, et al
    Epidemic mitigation by statistical inference from contact tracing data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  448. SINCLAIR AH, Hakimi S, Stanley ML, Adcock RA, et al
    Pairing facts with imagined consequences improves pandemic-related risk perception.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  449. BETSCH C, Sprengholz P, Siegers R, Eitze S, et al
    Empirical evidence to understand the human factor for effective rapid testing against SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  450. RUDIGER S, Konigorski S, Rakowski A, Edelman JA, et al
    Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  451. ARCHIBONG B, Metcalf CJE
    Building toward useful SARS-CoV-2 models in Africa.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  452. IRONS NJ, Raftery AE
    Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  453. HAN X, Xu Y, Fan L, Huang Y, et al
    Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    July 2021
  454. DE LIMA LF, Ferreira AL, Torres MDT, de Araujo WR, et al
    Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  455. STAQUICINI DI, Tang FHF, Markosian C, Yao VJ, et al
    Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  456. JANG WD, Jeon S, Kim S, Lee SY, et al
    Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  457. KERR GH, Goldberg DL, Anenberg SC
    COVID-19 pandemic reveals persistent disparities in nitrogen dioxide pollution.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  458. DAMPALLA CS, Zheng J, Perera KD, Wong LR, et al
    Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  459. WANG Y, Yang C, Song Y, Coleman JR, et al
    Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  460. GOLDSTEIN JR, Cassidy T, Wachter KW
    Reply to Dushoff et al. and Pifarre i Arolas et al.: Age prioritization for COVID-19 vaccination does save lives and years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  461. DUSHOFF J, Colijn C, Earn DJD, Bolker BM, et al
    Transmission dynamics are crucial to COVID-19 vaccination policy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  462. JELLIFFE E, Pangburn P, Pichler S, Ziebarth NR, et al
    Awareness and use of (emergency) sick leave: US employees' unaddressed sick leave needs in a global pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  463. ROCHMAN ND, Wolf YI, Faure G, Mutz P, et al
    Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  464. ZHANG H, Zhu W, Jin Q, Pan F, et al
    Inhalable nanocatchers for SARS-CoV-2 inhibition.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  465. PETERSEN MB, Bor A, Jorgensen F, Lindholt MF, et al
    Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  466. ORNES S
    Science and Culture: The evolving portrait of a virus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  467. TSCHERNE A, Schwarz JH, Rohde C, Kupke A, et al
    Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  468. SSENTONGO P, Fronterre C, Geronimo A, Greybush SJ, et al
    Pan-African evolution of within- and between-country COVID-19 dynamics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  469. IMAI M, Halfmann PJ, Yamayoshi S, Iwatsuki-Horimoto K, et al
    Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  470. SALON D, Conway MW, Capasso da Silva D, Chauhan RS, et al
    The potential stickiness of pandemic-induced behavior changes in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  471. STOHNER J
    Does exhaled aerosol increase with COVID-19 infection correlate with body mass index-years?
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  472. RHINEY K, Guido Z, Knudson C, Avelino J, et al
    Epidemics and the future of coffee production.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  473. SILVERSTEIN NJ, Luban J
    Lessons from a local effort to screen for SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  474. PENG T, Du SY, Son M, Diamond B, et al
    HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  475. PERSSON J, Parie JF, Feuerriegel S
    Monitoring the COVID-19 epidemic with nationwide telecommunication data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  476. YANG J, Wen Y, Wang Y, Zhang S, et al
    From COVID-19 to future electrification: Assessing traffic impacts on air quality by a machine-learning model.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  477. KLINE D, Li Z, Chu Y, Wakefield J, et al
    Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  478. SARR D, Gingerich AD, Asthiwi NM, Almutairi F, et al
    Dual oxidase 1 promotes antiviral innate immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  479. SENDER R, Bar-On YM, Gleizer S, Bernshtein B, et al
    The total number and mass of SARS-CoV-2 virions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  480. SCHMELZ K, Bowles S
    Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  481. REES CA, Rostad CA, Mantus G, Anderson EJ, et al
    Altered amino acid profile in patients with SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  482. SMITH TP, Flaxman S, Gallinat AS, Kinosian SP, et al
    Temperature and population density influence SARS-CoV-2 transmission in the absence of nonpharmaceutical interventions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  483. HOU X, Gao S, Li Q, Kang Y, et al
    Intracounty modeling of COVID-19 infection with human mobility: Assessing spatial heterogeneity with business traffic, age, and race.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  484. HSU JC, Laurent-Rolle M, Pawlak JB, Wilen CB, et al
    Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  485. SIEGRIST M, Bearth A
    Worldviews, trust, and risk perceptions shape public acceptance of COVID-19 public health measures.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  486. ROCK C, Zenilman J
    Opinion: How to ensure regulations don't stymie much-needed COVID-19 point-of-care testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  487. SATO-KANEKO F, Yao S, Lao FS, Nan J, et al
    Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  488. MCCARTHY KR, Von Holle TA, Sutherland LL, Oguin TH 3rd, et al
    Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  489. ZHANG Y, Chen Y, Li Y, Huang F, et al
    The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  490. LEVER J, Altman RB
    Analyzing the vast coronavirus literature with CoronaCentral.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  491. LU JG, Jin P, English AS
    Collectivism predicts mask use during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  492. ZHAO J, Jaffe A, Li H, Lindenbaum O, et al
    Detection of differentially abundant cell subpopulations in scRNA-seq data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  493. WU Y, Mooring TA, Linz M
    Policy and weather influences on mobility during the early US COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  494. SIA ZR, He X, Zhang A, Ang JC, et al
    A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    May 2021
  495. KANG S, Tanaka T, Inoue H, Ono C, et al
    Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  496. CHENG L, Zhu Z, Wang C, Wang P, et al
    COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  497. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  498. GENG X, Katul GG, Gerges F, Bou-Zeid E, et al
    A kernel-modulated SIR model for Covid-19 contagious spread from county to continent.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  499. DEMORA SL, Merolla JL, Newman B, Zechmeister EJ, et al
    Reducing mask resistance among White evangelical Christians with value-consistent messages.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  500. YANG Q, Saldi TK, Gonzales PK, Lasda E, et al
    Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  501. REINHART E, Chen DL
    Carceral-community epidemiology, structural racism, and COVID-19 disparities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  502. CHUMAKOV K, Avidan MS, Benn CS, Bertozzi SM, et al
    Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  503. MCDERMOTT A
    Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  504. STAMBAUGH A, Parks JW, Stott MA, Meena GG, et al
    Optofluidic multiplex detection of single SARS-CoV-2 and influenza A antigens using a novel bright fluorescent probe assay.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  505. MILKMAN KL, Patel MS, Gandhi L, Graci HN, et al
    A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  506. GREMESE E, Alivernini S, Ferraccioli G
    RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  507. GURRIERI L, Fairbairn CE, Sayette MA, Bosch N, et al
    Alcohol narrows physical distance between strangers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  508. MALONE B, Chen J, Wang Q, Llewellyn E, et al
    Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  509. DONG C, Wang Y, Gonzalez GX, Ma Y, et al
    Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  510. MORSELLI GYSI D, do Valle I, Zitnik M, Ameli A, et al
    Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  511. NI X, Ouyang W, Jeong H, Kim JT, et al
    Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  512. PYMM P, Adair A, Chan LJ, Cooney JP, et al
    Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  513. KRUCZKIEWICZ A, Klopp J, Fisher J, Mason S, et al
    Opinion: Compound risks and complex emergencies require new approaches to preparedness.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  514. HREBIK D, Fuzik T, Gondova M, Smerdova L, et al
    ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  515. CHANDRASEKHAR AG, Goldsmith-Pinkham P, Jackson MO, Thau S, et al
    Interacting regional policies in containing a disease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  516. MAEDA DLNF, Tian D, Yu H, Dar N, et al
    Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  517. SAWATZKI K, Hill NJ, Puryear WB, Foss AD, et al
    Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  518. BAIR E, Stillinger T, Rittger K, Skiles M, et al
    COVID-19 lockdowns show reduced pollution on snow and ice in the Indus River Basin.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  519. SWANK Z, Michielin G, Yip HM, Cohen P, et al
    A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  520. GALEA S
    Understanding why we do what we do during a global pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


    April 2021
  521. TKACHENKO AV, Maslov S, Elbanna A, Wong GN, et al
    Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  522. MENA EL, Donahue CJ, Vaites LP, Li J, et al
    ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  523. ENGZELL P, Frey A, Verhagen MD
    Learning loss due to school closures during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  524. BAZANT MZ, Bush JWM
    A guideline to limit indoor airborne transmission of COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  525. YAN Y, Malik AA, Bayham J, Fenichel EP, et al
    Measuring voluntary and policy-induced social distancing behavior during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  526. BUCKNER JH, Chowell G, Springborn MR
    Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  527. PRESTON SH, Vierboom YC
    Excess mortality in the United States in the 21st century.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  528. CASTRO MC, Singer B
    Prioritizing COVID-19 vaccination by age.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  529. KRAUS S, Koch N
    Provisional COVID-19 infrastructure induces large, rapid increases in cycling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  530. RIZZI S, Vaupel JW
    Short-term forecasts of expected deaths.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  531. HE X, Quan S, Xu M, Rodriguez S, et al
    Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  532. BERRY CR, Fowler A, Glazer T, Handel-Meyer S, et al
    Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  533. GRANGE ZL, Goldstein T, Johnson CK, Anthony S, et al
    Ranking the risk of animal-to-human spillover for newly discovered viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  534. SCHEUFELE DA, Hoffman AJ, Neeley L, Reid CM, et al
    Misinformation about science in the public sphere.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  535. KORN L, Bohm R, Betsch C
    Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  536. SNEPPEN K, Nielsen BF, Taylor RJ, Simonsen L, et al
    Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  537. BJERRE-NIELSEN A, Kassarnig V, Lassen DD, Lehmann S, et al
    Task-specific information outperforms surveillance-style big data in predictive analytics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  538. RABB N, Glick D, Houston A, Bowers J, et al
    No evidence that collective-good appeals best promote COVID-related health behaviors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  539. JO WK, Schadenhofer A, Habierski A, Kaiser FK, et al
    Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  540. WEISEL O
    Vaccination as a social contract: The case of COVID-19 and US political partisanship.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  541. HONG B, Bonczak BJ, Gupta A, Thorpe LE, et al
    Exposure density and neighborhood disparities in COVID-19 infection risk.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  542. CONLEY D, Johnson T
    Opinion: Past is future for the era of COVID-19 research in the social sciences.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  543. MENDELS DA, Dortet L, Emeraud C, Oueslati S, et al
    Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  544. LIU Y, Hu G, Wang Y, Ren W, et al
    Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  545. SINGH S, Shaikh M, Hauck K, Miraldo M, et al
    Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  546. LIU R, Americo JL, Cotter CA, Earl PL, et al
    One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  547. LU M, Dravid P, Zhang Y, Trivedi S, et al
    A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  548. DAMIALIS A, Gilles S, Sofiev M, Sofieva V, et al
    Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  549. GIURGE LM, Whillans AV, Yemiscigil A
    A multicountry perspective on gender differences in time use during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  550. JI W, Li X, Chen S, Ren L, et al
    Transmission of SARS-CoV-2 via fomite, especially cold chain, should not be ignored.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  551. SHUMSKY RA, Debo L, Lebeaux RM, Nguyen QP, et al
    Retail store customer flow and COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  552. GOLDSTEIN JR, Cassidy T, Wachter KW
    Vaccinating the oldest against COVID-19 saves both the most lives and most years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  553. KIZILCEC RF, Makridis CA, Sadowski KC
    Pandemic response policies' democratizing effects on online learning.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  554. THURNER S, Klimek P, Hanel R
    Reply to Kusmierz and Toyoizumi: A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  555. KAPLAN RM, Milstein A
    Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  556. LI K, Jacob DJ, Liao H, Qiu Y, et al
    Ozone pollution in the North China Plain spreading into the late-winter haze season.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  557. ZEBERG H, Paabo S
    A genomic region associated with protection against severe COVID-19 is inherited from Neandertals.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  558. CLARK SJ, Turner AN
    Monitoring epidemics: Lessons from measuring population prevalence of the coronavirus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  559. BENTON DJ, Wrobel AG, Roustan C, Borg A, et al
    The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  560. VLACHOS J, Hertegard E, B Svaleryd H
    The effects of school closures on SARS-CoV-2 among parents and teachers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  561. GIUNTELLA O, Hyde K, Saccardo S, Sadoff S, et al
    Lifestyle and mental health disruptions during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  562. SUBRAMANIAN R, He Q, Pascual M
    Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  563. NADEAU SA, Vaughan TG, Scire J, Huisman JS, et al
    The origin and early spread of SARS-CoV-2 in Europe.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  564. FREYN AW, Han J, Guthmiller JJ, Bailey MJ, et al
    Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  565. LI Z, Lin Y, Huang YY, Liu R, et al
    Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  566. MA C, Wang J
    Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  567. EDWARDS DA, Ausiello D, Salzman J, Devlin T, et al
    Exhaled aerosol increases with COVID-19 infection, age, and obesity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  568. PERRY BL, Aronson B, Pescosolido BA
    Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  569. FAZIO RH, Ruisch BC, Moore CA, Granados Samayoa JA, et al
    Social distancing decreases an individual's likelihood of contracting COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  570. NEANT N, Lingas G, Le Hingrat Q, Ghosn J, et al
    Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  571. AZIMI P, Keshavarz Z, Cedeno Laurent JG, Stephens B, et al
    Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  572. XIE W, Zhang W
    Reply to Marot et al.: The struggle to comply with social-distancing is multifaceted, as are the ways of mitigating it.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  573. MAROT M, Chevalere J, Spatola N
    Depressed mood, a better predictor of social-distancing compliance and candidate for intervention compared to working memory capacity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  574. TORRATS-ESPINOSA G
    Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  575. KVEDARAITE E, Hertwig L, Sinha I, Ponzetta A, et al
    Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  576. LAPOINTE CP, Grosely R, Johnson AG, Wang J, et al
    Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  577. FINLAY BB, Amato KR, Azad M, Blaser MJ, et al
    The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  578. WITTEMAN HO, Haverfield J, Tannenbaum C
    COVID-19 gender policy changes support female scientists and improve research quality.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  579. SASISEKHARAN V, Pentakota N, Jayaraman A, Tharakaraman K, et al
    Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  580. ANDRASFAY T, Goldman N
    Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  581. YIANNOUTSOS CT, Halverson PK, Menachemi N
    Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  582. BORCHERING RK, Gunning CE, Gokhale DV, Weedop KB, et al
    Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  583. JAN JT, Cheng TR, Juang YP, Ma HH, et al
    Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    January 2021
  584. HOWARD J, Huang A, Li Z, Tufekci Z, et al
    An evidence review of face masks against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  585. MARZIANO V, Guzzetta G, Rondinone BM, Boccuni F, et al
    Retrospective analysis of the Italian exit strategy from COVID-19 lockdown.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  586. BERGER L, Berger N, Bosetti V, Gilboa I, et al
    Rational policymaking during a pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  587. HANNA CC, Ashhurst AS, Quan D, Maxwell JWC, et al
    Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  588. GIGLIO S, Maggiori M, Stroebel J, Utkus S, et al
    The joint dynamics of investor beliefs and trading during the COVID-19 crash.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  589. HOPKINS DJ, Meredith M, Chainani A, Olin N, et al
    Results from a 2020 field experiment encouraging voting by mail.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  590. RAPPUOLI R, De Gregorio E, Del Giudice G, Phogat S, et al
    Vaccinology in the post-COVID-19 era.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  591. VOUTOURI C, Nikmaneshi MR, Hardin CC, Patel AB, et al
    In silico dynamics of COVID-19 phenotypes for optimizing clinical management.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  592. EVENSEN D, Whitmarsh L, Bartie P, Devine-Wright P, et al
    Effect of "finite pool of worry" and COVID-19 on UK climate change perceptions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  593. PARK SW, Sun K, Champredon D, Li M, et al
    Forward-looking serial intervals correctly link epidemic growth to reproduction numbers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  594. BERENBAUM MR
    On COVID-19, cognitive bias, and open access.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  595. CHEN MK, Chevalier JA, Long EF
    Nursing home staff networks and COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  596. CARLETON T, Cornetet J, Huybers P, Meng KC, et al
    Global evidence for ultraviolet radiation decreasing COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  597. CIPPA PE, Cugnata F, Ferrari P, Brombin C, et al
    A data-driven approach to identify risk profiles and protective drugs in COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  598. LI R
    Mobility restrictions are more than transient reduction of travel activities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  599. SIMONESCHI D
    Opinion: We need to improve the welfare of life science trainees.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  600. LIU K, Tan S, Niu S, Wang J, et al
    Cross-species recognition of SARS-CoV-2 to bat ACE2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  601. MUELLER JT, McConnell K, Burow PB, Pofahl K, et al
    Impacts of the COVID-19 pandemic on rural America.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  602. JUNG H, Albarracin D
    Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  603. SCHMELZ K
    Enforcement may crowd out voluntary support for COVID-19 policies, especially where trust in government is weak and in a liberal society.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  604. SCHLOSSER F, Maier BF, Jack O, Hinrichs D, et al
    COVID-19 lockdown induces disease-mitigating structural changes in mobility networks.
    Proc Natl Acad Sci U S A. 2020;117:32883-32890.
    PubMed     Abstract available


  605. CENTOLA D
    Considering network interventions.
    Proc Natl Acad Sci U S A. 2020;117:32833-32835.
    PubMed    


  606. MITZE T, Kosfeld R, Rode J, Walde K, et al
    Face masks considerably reduce COVID-19 cases in Germany.
    Proc Natl Acad Sci U S A. 2020;117:32293-32301.
    PubMed     Abstract available


  607. WEITZ JS, Park SW, Eksin C, Dushoff J, et al
    Awareness-driven behavior changes can shift the shape of epidemics away from peaks and toward plateaus, shoulders, and oscillations.
    Proc Natl Acad Sci U S A. 2020;117:32764-32771.
    PubMed     Abstract available


  608. ZANG R, Case JB, Yutuc E, Ma X, et al
    Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.
    Proc Natl Acad Sci U S A. 2020;117:32105-32113.
    PubMed     Abstract available


  609. TUPPER P, Boury H, Yerlanov M, Colijn C, et al
    Event-specific interventions to minimize COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:32038-32045.
    PubMed     Abstract available


  610. TAYLOR CA, Boulos C, Almond D
    Livestock plants and COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:31706-31715.
    PubMed     Abstract available


  611. WANG Y, Mao Q, Zhou X
    Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
    Proc Natl Acad Sci U S A. 2020;117:30896-30897.
    PubMed    


  612. ZENG HL, Dichio V, Rodriguez Horta E, Thorell K, et al
    Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
    Proc Natl Acad Sci U S A. 2020;117:31519-31526.
    PubMed     Abstract available


  613. XU X, Han M, Li T, Sun W, et al
    Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients.
    Proc Natl Acad Sci U S A. 2020;117:30898-30899.
    PubMed    


  614. YANG C, Liu E, Liu M
    Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2020;117:30025-30026.
    PubMed    


  615. XU X, Han M, Li T, Sun W, et al
    Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.
    Proc Natl Acad Sci U S A. 2020;117:30027-30028.
    PubMed    


  616. NISHI A, Dewey G, Endo A, Neman S, et al
    Network interventions for managing the COVID-19 pandemic and sustaining economy.
    Proc Natl Acad Sci U S A. 2020;117:30285-30294.
    PubMed     Abstract available


  617. CASADEVALL A, Pirofski LA
    In fatal COVID-19, the immune response can control the virus but kill the patient.
    Proc Natl Acad Sci U S A. 2020;117:30009-30011.
    PubMed    


  618. KORTESSIS N, Simon MW, Barfield M, Glass GE, et al
    The interplay of movement and spatiotemporal variation in transmission degrades pandemic control.
    Proc Natl Acad Sci U S A. 2020;117:30104-30106.
    PubMed     Abstract available


  619. BAKER RE, Park SW, Yang W, Vecchi GA, et al
    The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.
    Proc Natl Acad Sci U S A. 2020;117:30547-30553.
    PubMed     Abstract available


  620. BANG A, Khadakkar S
    Opinion: Biodiversity conservation during a global crisis: Consequences and the way forward.
    Proc Natl Acad Sci U S A. 2020;117:29995-29999.
    PubMed    


    November 2020
  621. HORNER C, Schurmann C, Auste A, Ebenig A, et al
    A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Nov 30. pii: 2014468117.
    PubMed     Abstract available


  622. SRIRAM K, Loomba R, Insel PA
    Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
    Proc Natl Acad Sci U S A. 2020;117:29274-29282.
    PubMed     Abstract available


  623. RELMAN DA
    Opinion: To stop the next pandemic, we need to unravel the origins of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:29246-29248.
    PubMed    


  624. LI W, Chen C, Drelich A, Martinez DR, et al
    Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2020;117:29832-29838.
    PubMed     Abstract available


  625. STOKES GL, Lynch AJ, Lowe BS, Funge-Smith S, et al
    COVID-19 pandemic impacts on global inland fisheries.
    Proc Natl Acad Sci U S A. 2020;117:29419-29421.
    PubMed     Abstract available


  626. WONG F, Collins JJ
    Evidence that coronavirus superspreading is fat-tailed.
    Proc Natl Acad Sci U S A. 2020;117:29416-29418.
    PubMed     Abstract available


  627. SENDER V, Hentrich K, Pathak A, Tan Qian Ler A, et al
    Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways.
    Proc Natl Acad Sci U S A. 2020 Nov 23. pii: 2012265117.
    PubMed     Abstract available


  628. WESTON S, Baracco L, Keller C, Matthews K, et al
    The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
    Proc Natl Acad Sci U S A. 2020 Nov 12. pii: 2012939117.
    PubMed     Abstract available


  629. MIORIN L, Kehrer T, Sanchez-Aparicio MT, Zhang K, et al
    SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
    Proc Natl Acad Sci U S A. 2020;117:28344-28354.
    PubMed     Abstract available


  630. SEITZ BM, Aktipis A, Buss DM, Alcock J, et al
    The pandemic exposes human nature: 10 evolutionary insights.
    Proc Natl Acad Sci U S A. 2020;117:27767-27776.
    PubMed     Abstract available


  631. LUMENG JC, Chavous TM, Lok AS, Sen S, et al
    Opinion: A risk-benefit framework for human research during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:27749-27753.
    PubMed    


  632. POLYAKOVA M, Kocks G, Udalova V, Finkelstein A, et al
    Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impacts.
    Proc Natl Acad Sci U S A. 2020;117:27934-27939.
    PubMed     Abstract available


  633. WU M, Chen Y, Xia H, Wang C, et al
    Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
    Proc Natl Acad Sci U S A. 2020;117:28336-28343.
    PubMed     Abstract available


  634. DOLGIN E
    Core Concept: The pandemic is prompting widespread use-and misuse-of real-world data.
    Proc Natl Acad Sci U S A. 2020;117:27754-27758.
    PubMed    


  635. XIONG C, Hu S, Yang M, Luo W, et al
    Mobile device data reveal the dynamics in a positive relationship between human mobility and COVID-19 infections.
    Proc Natl Acad Sci U S A. 2020;117:27087-27089.
    PubMed     Abstract available


  636. GALASSO V, Pons V, Profeta P, Becher M, et al
    Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries.
    Proc Natl Acad Sci U S A. 2020;117:27285-27291.
    PubMed     Abstract available


  637. MEROW C, Urban MC
    Seasonality and uncertainty in global COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2020;117:27456-27464.
    PubMed     Abstract available


  638. LI Z, Li X, Huang YY, Wu Y, et al
    Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.
    Proc Natl Acad Sci U S A. 2020;117:27381-27387.
    PubMed     Abstract available


  639. WITTEVEEN D, Velthorst E
    Economic hardship and mental health complaints during COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:27277-27284.
    PubMed     Abstract available


  640. RAO L, Xia S, Xu W, Tian R, et al
    Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.
    Proc Natl Acad Sci U S A. 2020;117:27141-27147.
    PubMed     Abstract available


  641. KAMPF G
    Protective effect of mandatory face masks in the public-relevant variables with likely impact on outcome were not considered.
    Proc Natl Acad Sci U S A. 2020;117:27076-27077.
    PubMed    


  642. NG QX, De Deyn MLZQ, Yeo WS
    Do face masks help? is not the question.
    Proc Natl Acad Sci U S A. 2020;117:27078-27079.
    PubMed    


    October 2020
  643. KAHN JP, Henry LM, Mastroianni AC, Chen WH, et al
    Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Proc Natl Acad Sci U S A. 2020 Oct 29. pii: 2021189117.
    PubMed    


  644. SORG RA, Gallay C, Van Maele L, Sirard JC, et al
    Synthetic gene-regulatory networks in the opportunistic human pathogen Streptococcus pneumoniae.
    Proc Natl Acad Sci U S A. 2020 Oct 21. pii: 1920015117.
    PubMed     Abstract available


  645. DOWD JB, Block P, Rotondi V, Mills MC, et al
    Dangerous to claim "no clear association" between intergenerational relationships and COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:25975-25976.
    PubMed    


  646. ARPINO B, Bordone V, Pasqualini M
    Reply to Dowd et al.: Dangerous to overemphasize the importance of specific COVID-19 risk factors based on (unadjusted) macro-level analyses.
    Proc Natl Acad Sci U S A. 2020;117:25977-25978.
    PubMed    


  647. CASTRO M, Ares S, Cuesta JA, Manrubia S, et al
    The turning point and end of an expanding epidemic cannot be precisely forecast.
    Proc Natl Acad Sci U S A. 2020;117:26190-26196.
    PubMed     Abstract available


  648. MCDERMOTT A
    Inner Workings: Researchers race to develop in-home testing for COVID-19, a potential game changer.
    Proc Natl Acad Sci U S A. 2020;117:25956-25959.
    PubMed    


  649. BOSCO-LAUTH AM, Hartwig AE, Porter SM, Gordy PW, et al
    Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats.
    Proc Natl Acad Sci U S A. 2020;117:26382-26388.
    PubMed     Abstract available


  650. LI R, Chen B, Zhang T, Ren Z, et al
    Global COVID-19 pandemic demands joint interventions for the suppression of future waves.
    Proc Natl Acad Sci U S A. 2020;117:26151-26157.
    PubMed     Abstract available


  651. CHENG MH, Zhang S, Porritt RA, Noval Rivas M, et al
    Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Proc Natl Acad Sci U S A. 2020;117:25254-25262.
    PubMed     Abstract available


  652. ABKARIAN M, Mendez S, Xue N, Yang F, et al
    Speech can produce jet-like transport relevant to asymptomatic spreading of virus.
    Proc Natl Acad Sci U S A. 2020;117:25237-25245.
    PubMed     Abstract available


  653. YAM KC, Jackson JC, Barnes CM, Lau J, et al
    The rise of COVID-19 cases is associated with support for world leaders.
    Proc Natl Acad Sci U S A. 2020;117:25429-25433.
    PubMed     Abstract available


  654. NETZ RR, Eaton WA
    Physics of virus transmission by speaking droplets.
    Proc Natl Acad Sci U S A. 2020;117:25209-25211.
    PubMed     Abstract available


  655. WILDER B, Charpignon M, Killian JA, Ou HC, et al
    Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City.
    Proc Natl Acad Sci U S A. 2020;117:25904-25910.
    PubMed     Abstract available


  656. BRETT TS, Rohani P
    Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
    Proc Natl Acad Sci U S A. 2020;117:25897-25903.
    PubMed     Abstract available


  657. RAKER EJ, Zacher M, Lowe SR
    Reply to Ng et al.: Not all trauma is the same, but lessons can be drawn from commonalities.
    Proc Natl Acad Sci U S A. 2020;117:25201-25202.
    PubMed    


  658. NG QX, Lim DY, Chee KT
    Not all trauma is the same.
    Proc Natl Acad Sci U S A. 2020;117:25200.
    PubMed    


  659. HEINDEL DW, Koppolu S, Zhang Y, Kasper B, et al
    Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity.
    Proc Natl Acad Sci U S A. 2020 Oct 12. pii: 2008203117.
    PubMed     Abstract available


  660. LOCKHART M, Hill SJ, Merolla J, Romero M, et al
    America's electorate is increasingly polarized along partisan lines about voting by mail during the COVID-19 crisis.
    Proc Natl Acad Sci U S A. 2020;117:24640-24642.
    PubMed     Abstract available


  661. HOLLAND KJ, Cortina LM, Magley VJ, Baker AL, et al
    Don't let COVID-19 disrupt campus climate surveys of sexual harassment.
    Proc Natl Acad Sci U S A. 2020;117:24606-24608.
    PubMed    


  662. SEGALES J, Puig M, Rodon J, Avila-Nieto C, et al
    Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
    Proc Natl Acad Sci U S A. 2020;117:24790-24793.
    PubMed     Abstract available


  663. HOLTER JC, Pischke SE, de Boer E, Lind A, et al
    Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
    Proc Natl Acad Sci U S A. 2020;117:25018-25025.
    PubMed     Abstract available


  664. STEINMAN JB, Lum FM, Ho PP, Kaminski N, et al
    Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics.
    Proc Natl Acad Sci U S A. 2020;117:24620-24626.
    PubMed     Abstract available


    September 2020
  665. ARORA VM, Wray CM, O'Glasser AY, Shapiro M, et al
    Using the curriculum vitae to promote gender equity during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:24032.
    PubMed    


  666. GROSSMAN G, Kim S, Rexer JM, Thirumurthy H, et al
    Political partisanship influences behavioral responses to governors' recommendations for COVID-19 prevention in the United States.
    Proc Natl Acad Sci U S A. 2020;117:24144-24153.
    PubMed     Abstract available


  667. THOMAS LJ, Huang P, Yin F, Luo XI, et al
    Spatial heterogeneity can lead to substantial local variations in COVID-19 timing and severity.
    Proc Natl Acad Sci U S A. 2020;117:24180-24187.
    PubMed     Abstract available


  668. HABEL JR, Nguyen THO, van de Sandt CE, Juno JA, et al
    Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype.
    Proc Natl Acad Sci U S A. 2020;117:24384-24391.
    PubMed     Abstract available


  669. RABE BA, Cepko C
    SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification.
    Proc Natl Acad Sci U S A. 2020;117:24450-24458.
    PubMed     Abstract available


  670. KARATAYEV VA, Anand M, Bauch CT
    Local lockdowns outperform global lockdown on the far side of the COVID-19 epidemic curve.
    Proc Natl Acad Sci U S A. 2020;117:24575-24580.
    PubMed     Abstract available


  671. LINDESTAM ARLEHAMN CS, Sette A, Peters B
    Lack of evidence for BCG vaccine protection from severe COVID-19.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2016733117.
    PubMed    


  672. PATELLA V, Delfino G, Bruzzese D, Giuliano A, et al
    The bacillus Calmette-Guerin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2015234117.
    PubMed    


  673. BARILLAS-MURY C, Escobar LE, Molina-Cruz A
    Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guerin (BCG) vaccination on COVID-19 prevalence and mortality.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2017197117.
    PubMed    


  674. MALISCH JL, Harris BN, Sherrer SM, Lewis KA, et al
    Reply to Arora et al.: Concerns and considerations about using the CV as an equity tool.
    Proc Natl Acad Sci U S A. 2020;117:24033-24034.
    PubMed    


  675. RAUSCH JW, Capoferri AA, Katusiime MG, Patro SC, et al
    Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2017726117.
    PubMed    


  676. GANGULI A, Mostafa A, Berger J, Aydin MY, et al
    Rapid isothermal amplification and portable detection system for SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020;117:22727-22735.
    PubMed     Abstract available


  677. THURNER S, Klimek P, Hanel R
    A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2020;117:22684-22689.
    PubMed     Abstract available


    August 2020
  678. DEARLOVE B, Lewitus E, Bai H, Li Y, et al
    A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2008281117.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.